<!DOCTYPE html>
<html lang="en" class="wkProspect"><head><meta http-equiv="origin-trial" content="A/kargTFyk8MR5ueravczef/wIlTkbVk1qXQesp39nV+xNECPdLBVeYffxrM8TmZT6RArWGQVCJ0LRivD7glcAUAAACQeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZS5jb206NDQzIiwiZmVhdHVyZSI6IkRpc2FibGVUaGlyZFBhcnR5U3RvcmFnZVBhcnRpdGlvbmluZzIiLCJleHBpcnkiOjE3NDIzNDIzOTksImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9">
  <title>跨性别女性的评估和管理 - UpToDate</title>
  <meta http-equiv="X-UA-Compatible" content="IE=Edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0">
  <meta name="apple-mobile-web-app-title" content="UpToDate">
  <meta name="format-detection" content="telephone=no">
  <link href="/app/utd-menu/utd-icon.png" rel="apple-touch-icon">
  <link rel="icon" type="image/png" href="/app/utd-menu/utd-icon-redesign.png">
  <meta name="fragment" content="!">
  <link rel="canonical" href="https://www.uptodate.com/contents/zh-Hans/transgender-women-evaluation-and-management/print">
  <meta name="description" content="">
  <meta charset="UTF-8">
  <style type="text/css">
    #appContainer {
      position: absolute;
      top: 0;
      right: 0;
      bottom: 0;
      left: 0;
      background: url(/app/utd-menu/utd-icon.png) no-repeat;
      background-attachment: fixed;
      background-position: center;
      background-size: 48px 48px;
    }
  </style>
  <!-- for prerender.io -->
  <script async="" type="text/plain" src="https://www.googletagmanager.com/gtm.js?id=GTM-53VFLLN" class="optanon-category-C0002 "></script><script type="text/javascript" async="" charset="utf-8" src="https://www.gstatic.com/recaptcha/releases/rW64dpMGAGrjU7JJQr9xxPl8/recaptcha__en.js" crossorigin="anonymous" integrity="sha384-stI8i0l4UnrupDOI6In0RQyfmG7x4RHoRSlzjf/yDu+T9clp2es/I4WNYpU4isM0"></script><script> window.prerenderReady = false; </script>
  <script type="text/javascript">
    function OptanonWrapper() {
      window.utd_OneTrustInitialized = true;
    }

    function isIE11() {
      return !!window.MSInputMethodContext && !!document.documentMode;
    }

    if (isIE11()) {
      window.location.href = '/unsupported.html';
    }
  </script>
  <script src="https://www.google.com/recaptcha/enterprise.js?render=explicit" async="" defer=""></script>
  <script>
    // Global wkPageData data layer   
    var wkPageData = window.wkPageData || {};    
    wkPageData.page = {
        "pageInfo": {
            "pageID": "",
            "pageTitle": ""
        },
        "category": {
            "businessUnit": "Health - CE - UpToDate", // mandatory, BU Assignment as used on OneWeb ({Division} - {Business Unit})
            "division": "Health" // mandatory, Division Assignment as used on OneWeb
        },
        "attributes": {
            "pageTemplate": "", // Optional, used in GA as custom dimension
            "pageLanguage": "en", // mandatory, language-country code as used on OneWeb
            "solution": "",
            "solutionSuite": "",
            "solutionHub": "",
            "funnelStage": ""
        }
    };    
  </script>

  <!-- index.js -->
  <!-- vendor.js -->
  <!-- utd-all.js -->
  <link rel="modulepreload" crossorigin="" href="/app/dist/epic-BTzdswjX.min.js">
  <link rel="stylesheet" crossorigin="" href="/app/assets/utd-all-D9t8Rwoe.css">
<link rel="modulepreload" as="script" crossorigin="" href="/app/dist/pace-BnSE3puv.min.js"><link rel="modulepreload" as="script" crossorigin="" href="/app/dist/vendor-Bd_R3RP5.min.js"><link id="utdGxGen" rel="stylesheet" type="text/css" href="/contents/assets/css/UTD_gx_gen.css"><script id="oneTrustCookieNotice"><script type="text/javascript" src="https://cdn.cookielaw.org/consent/560a8aa4-c54c-486f-9bc4-35a3f22bacd9/OtAutoBlock.js" id="oneTrustSelectionScript"></script><script type="text/javascript" src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" charset="UTF-8" data-domain-script="560a8aa4-c54c-486f-9bc4-35a3f22bacd9"></script></script><link type="application/opensearchdescription+xml" rel="search" title="UpToDate to Search Plugin" href="/xml/search.xml"><script src="https://cdn.cookielaw.org/scripttemplates/202301.1.0/otBannerSdk.js" async="" type="text/javascript"></script><style id="onetrust-style">#onetrust-banner-sdk{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{height:64px;width:64px}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:0.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-banner-sdk button.ot-link-btn:hover,#onetrust-pc-sdk button.ot-link-btn:hover,#ot-sync-ntfy button.ot-link-btn:hover{text-decoration:underline;opacity:1}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type="checkbox"]:checked,#onetrust-pc-sdk [type="checkbox"]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type="checkbox"]:disabled+label::before,#onetrust-pc-sdk [type="checkbox"]:disabled+label:after,#onetrust-pc-sdk [type="checkbox"]:disabled+label{pointer-events:none;opacity:0.7}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type="checkbox"]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type="checkbox"]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px 0.1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat;display:inline-flex;justify-content:center;align-items:center}#onetrust-pc-sdk .pc-logo img,#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;max-width:100%}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#68b631;border:1px solid #68b631;height:auto;white-space:normal;word-wrap:break-word;padding:0.8em 2em;font-size:0.8em;line-height:1.2;cursor:pointer;-moz-transition:0.1s ease;-o-transition:0.1s ease;-webkit-transition:1s ease;transition:0.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#68b631}.onetrust-pc-dark-filter{background:rgba(0,0,0,0.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px) and (max-width: 896px) and (orientation: landscape){#onetrust-pc-sdk p{font-size:0.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info a{margin-right:auto}#onetrust-pc-sdk .ot-pc-footer-logo img{width:136px;height:16px}#onetrust-banner-sdk .ot-optout-signal,#onetrust-pc-sdk .ot-optout-signal{border:1px solid #32ae88;border-radius:3px;padding:5px;margin-bottom:10px;background-color:#f9fffa;font-size:0.85rem;line-height:2}#onetrust-banner-sdk .ot-optout-signal .ot-optout-icon,#onetrust-pc-sdk .ot-optout-signal .ot-optout-icon{display:inline;margin-right:5px}#onetrust-banner-sdk .ot-optout-signal svg,#onetrust-pc-sdk .ot-optout-signal svg{height:20px;width:30px;transform:scale(0.5)}#onetrust-banner-sdk .ot-optout-signal svg path,#onetrust-pc-sdk .ot-optout-signal svg path{fill:#32ae88}
#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:"";content:none}
#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media (min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media (min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media (min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:0.9em;font-weight:400;line-height:38px;letter-spacing:0.01em;text-decoration:none;white-space:nowrap;background-color:transparent;border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus{color:#333;border-color:#888;opacity:0.7}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type="submit"].ot-sdk-button-primary,#onetrust-banner-sdk input[type="reset"].ot-sdk-button-primary,#onetrust-banner-sdk input[type="button"].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type="submit"].ot-sdk-button-primary,#onetrust-pc-sdk input[type="reset"].ot-sdk-button-primary,#onetrust-pc-sdk input[type="button"].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type="submit"].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type="reset"].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type="button"].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type="submit"].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type="reset"].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type="button"].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type="submit"].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type="reset"].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type="button"].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type="submit"].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type="reset"].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type="button"].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type="submit"].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type="reset"].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type="button"].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type="submit"].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type="reset"].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type="button"].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type="submit"].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type="reset"].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type="button"].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type="text"],#onetrust-pc-sdk input[type="text"],#ot-sdk-cookie-policy input[type="text"]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type="text"],#onetrust-pc-sdk input[type="text"],#ot-sdk-cookie-policy input[type="text"]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type="text"]:focus,#onetrust-pc-sdk input[type="text"]:focus,#ot-sdk-cookie-policy input[type="text"]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:0.5rem;font-weight:600}#onetrust-banner-sdk input[type="checkbox"],#onetrust-pc-sdk input[type="checkbox"],#ot-sdk-cookie-policy input[type="checkbox"]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}
#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFloatingRounded{position:fixed;background-color:#fff;width:60%;max-width:700px;z-index:2147483645;border-radius:2.5px;bottom:2em;left:1em;font-size:16px;max-height:90%;overflow-y:auto;overflow-x:hidden}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk.ot-bottom-left[dir=rtl]{right:1em}#onetrust-banner-sdk.ot-bottom-right{left:auto;right:1em}#onetrust-banner-sdk.ot-bottom-right[dir=rtl]{left:1em;right:auto}#onetrust-banner-sdk .accept-btn-only{float:none !important;width:100%}#onetrust-banner-sdk .cookie-settings-btn-only{width:100%}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk h3{margin-bottom:0}#onetrust-banner-sdk h3,#onetrust-banner-sdk p{color:dimgray}#onetrust-banner-sdk .ot-sdk-container{padding:0;width:100%;margin:0}#onetrust-banner-sdk #onetrust-policy{margin-top:40px}#onetrust-banner-sdk .ot-optout-signal{margin:0 1.875rem .625rem 1.875rem}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-button-group{float:left}#onetrust-banner-sdk #onetrust-button-group-parent{padding:10px 30px 4px 30px}#onetrust-banner-sdk .ot-gv-list-handler{padding:0 30px 10px 30px;font-size:.812em;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-b-addl-desc{padding:0 30px 10px 30px;clear:both;font-size:.813em;line-height:1.5;margin:0}#onetrust-banner-sdk #onetrust-policy-text>*,#onetrust-banner-sdk #onetrust-policy-text a,#onetrust-banner-sdk .ot-b-addl-desc>*,#onetrust-banner-sdk .ot-b-addl-desc a{margin-bottom:0px;font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a,#onetrust-banner-sdk .ot-b-addl-desc a{font-weight:bold}#onetrust-banner-sdk .ot-b-addl-desc{display:block}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{padding:0;margin-top:10px;margin-bottom:10px;line-height:1.5;font-size:1em}#onetrust-banner-sdk #onetrust-policy-title{display:inline-block;max-width:calc(100% - 75px);padding-left:30px;font-size:1em;line-height:1.5;padding-bottom:10px}#onetrust-banner-sdk #onetrust-button-group{float:right}#onetrust-banner-sdk .onetrust-banner-options{float:right;max-width:55%}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:130px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-weight:600;font-size:.813em}#onetrust-banner-sdk #onetrust-accept-btn-handler{margin-right:0}#onetrust-banner-sdk #onetrust-pc-btn-handler{border:1px solid #68b631;min-width:175px;max-width:40%}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;margin-right:1rem}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:100%}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{text-align:left;padding-left:0;padding-right:0}#onetrust-banner-sdk #onetrust-close-btn-container{right:20px;top:10px;position:absolute}#onetrust-banner-sdk .ot-close-icon{height:44px;width:44px;background-size:12px;margin:-10px -10px 0 0;display:inline-block;border:none;padding:0px}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-policy{margin-top:75px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{position:absolute;top:10px}#onetrust-banner-sdk #banner-options{float:left;padding:0 30px 0 30px;width:calc(100% - 60px)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 6px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{height:auto;display:block}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option{margin-bottom:10px}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-arrow-container{display:inline-block;border-top:6px solid transparent;border-bottom:6px solid transparent;border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;height:0px;padding:10px 10px 5px 10px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-dpd-container{float:left;padding:0 30px 0 30px;clear:both}#onetrust-banner-sdk .ot-dpd-title{font-weight:bold;padding-bottom:10px;line-height:1.4;font-size:1em}#onetrust-banner-sdk .ot-dpd-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc .onetrust-vendors-list-handler{display:block;margin-left:0px;margin-top:5px;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-text a{margin-left:5px}#onetrust-banner-sdk :not(.ot-dpd-desc)>.ot-b-addl-desc{font-size:.813em;line-height:1.5;margin:0;padding-bottom:10px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk.ot-close-btn-link.ot-wo-title #onetrust-group-container{margin-top:20px}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-button-group{margin-top:0}#onetrust-banner-sdk button{padding:0 20px}#onetrust-banner-sdk #onetrust-close-btn-container{right:15px}#onetrust-banner-sdk #onetrust-policy-title{padding-left:15px}#onetrust-banner-sdk #onetrust-button-group-parent,#onetrust-banner-sdk .ot-dpd-container{padding:0 15px 0px 15px}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-gv-list-handler,#onetrust-banner-sdk :not(.ot-dpd-desc)>.ot-b-addl-desc{padding:0 15px 10px 15px}#onetrust-banner-sdk .ot-optout-signal{margin:0 1.875rem .625rem 1.875rem}#onetrust-banner-sdk #ot-gv-link-ctnr{margin-bottom:15px}#onetrust-banner-sdk #onetrust-button-group button{width:100%}#onetrust-banner-sdk #banner-options{padding:0 15px 0 15px;width:calc(100% - 30px)}#onetrust-banner-sdk .banner-option{margin-bottom:6px}#onetrust-banner-sdk #onetrust-button-group,#onetrust-banner-sdk .onetrust-banner-options{width:100%}#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-right:0px}#onetrust-banner-sdk.otFloatingRounded,#onetrust-banner-sdk.otFloatingRounded[dir=rtl]{left:0;bottom:0;width:100%;right:0}}@media only screen and (max-width: 550px){#onetrust-banner-sdk .ot-close-icon{padding:0}#onetrust-banner-sdk.ot-close-btn-link #onetrust-group-container{margin-top:20px}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk.otFloatingRounded{width:95%}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%}}@media only screen and (max-width: 640px){#onetrust-banner-sdk #onetrust-button-group{text-align:center}#onetrust-banner-sdk .onetrust-banner-options,#onetrust-banner-sdk #onetrust-pc-btn-handler{max-width:100%;display:inline-block;text-align:center}#onetrust-banner-sdk .has-reject-all-button .onetrust-banner-options{width:100%}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFFFFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                    #onetrust-consent-sdk #onetrust-policy-text,
                    #onetrust-consent-sdk .ot-b-addl-desc,
                    #onetrust-consent-sdk .ot-dpd-desc,
                    #onetrust-consent-sdk .ot-dpd-title,
                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,
                    #onetrust-banner-sdk .ot-cat-header,
                    #onetrust-banner-sdk .ot-optout-signal
                    {
                        color: #232323;
                    }
            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {
                    background-color: #ededed;}
             #onetrust-consent-sdk #onetrust-banner-sdk a[href],
                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,
                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn
                        {
                            color: #007AC3;
                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler {
                            background-color: #007AC3;border-color: #007AC3;
                color: #FFFFFF;
            }
            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,
            #onetrust-consent-sdk #onetrust-banner-sdk:focus {
               outline-color: #000000;
               outline-width: 1px;
            }
            #onetrust-consent-sdk #onetrust-pc-btn-handler,
            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                color: #007AC3; border-color: #007AC3;
                background-color:
                #FFFFFF;
            }@media only screen and (min-width: 1280px)
{
#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container {
    width: 100%;
}


#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent {
    width: 100%;
}

}

#onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
	margin: 0;
	max-width: 100%;}

#onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link:hover {
    background-color: #fff !important;
    border-color: none !important;
    color: #003d61 !important;
    text-decoration: none !important;
}

#onetrust-banner-sdk #onetrust-button-group-parent #onetrust-button-group {
flex-direction: column-reverse;
display: flex;
}

#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type {
}

#onetrust-banner-sdk #onetrust-policy-text, #onetrust-banner-sdk .ot-dpd-desc, #onetrust-banner-sdk .ot-b-addl-desc {
    font-size: 12px;
    line-height: 22px;
}

#onetrust-banner-sdk #onetrust-accept-btn-handler, #onetrust-banner-sdk #onetrust-reject-all-handler, #onetrust-banner-sdk #onetrust-pc-btn-handler {
    line-height: 24px;
    flex-grow: 100;
    font-size: 12px;
    font-weight: 600;
    min-width: 0;
}

#onetrust-banner-sdk .ot-sdk-container {
    padding: 0;
    margin: 0;
}

#onetrust-banner-sdk .ot-sdk-row, #onetrust-pc-sdk .ot-sdk-row, #ot-sdk-cookie-policy .ot-sdk-row {
    padding: 20px 0;
}

#onetrust-pc-sdk button {
  font-weight: 400 !important;
  border-radius: 0 !important;
  max-width: none;
} 
#onetrust-banner-sdk button {
  font-weight: 400 !important;
  border-radius: 0 !important;
} 
#onetrust-pc-sdk #onetrust-button-group>button:focus,
#onetrust-banner-sdk #onetrust-button-group>button:focus,
#ot-pc-content>button:focus,
#onetrust-consent-sdk #onetrust-pc-sdk *:focus, #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus#onetrust-consent-sdk #onetrust-banner-sdk a:focus,
#onetrust-consent-sdk #onetrust-banner-sdk #onetrust-close-btn-container .banner-close-button.ot-close-icon:focus
#onetrust-consent-sdk #onetrust-banner-sdk *:focus {
 outline: 1px solid #000 !important;
 outline-offset: 0 !important; 
}
.ot-tgl input:focus {
 outline-offset: 0;
}
.ot-pc-desc a, 
#onetrust-banner-sdk #onetrust-policy-text a {
  font-weight: 400 !important;
  margin-left: 0px;
}
#ot-pc-desc a:hover, 
#onetrust-banner-sdk #onetrust-policy-text a:hover,
#onetrust-consent-sdk #onetrust-banner-sdk a[href]:hover,
#ot-pc-content.ot-pc-scrollbar a:hover,
#onetrust-pc-sdk :not(.ot-leg-btn-container)>button.ot-link-btn:hover,
#onetrust-pc-sdk .ot-pc-footer .ot-btn-container .ot-pc-refuse-all-handler:hover {
 color: #003d61 !important;
 text-decoration: none;
}
#onetrust-pc-sdk #ot-pc-content.ot-pc-scrollbar {
  padding-left: 30px;
  margin-left: 0;
}
 @media (max-width: 600px) {
  #onetrust-pc-sdk #ot-pc-content.ot-pc-scrollbar {
    padding-left: 20px;
  }
 }
#onetrust-banner-sdk #onetrust-button-group #onetrust-reject-all-handler {
  color: #FFFFFF;
  border-color: #007AC3;
  background-color: #007AC3;
}
#onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler.ot-link-btn {
  padding: 12px 16px;
  padding-left: 16px;
  margin-left: -16px;
}
#onetrust-pc-sdk .ot-pc-footer .ot-btn-container .ot-pc-refuse-all-handler {
    appearance: none;
    border: 0.0625rem solid transparent !important;
    border-radius: 0;
    background-color: transparent !important;
    color: #007AC3 !important;
    font-weight: 400;
    margin-right: 0 !important;
}
#onetrust-consent-sdk #onetrust-banner-sdk:focus{
  outline: none !important;
}
#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon {
 margin-right: 3px;
}
#onetrust-pc-sdk #ot-pc-content.ot-pc-scrollbar #ot-pc-title,
#onetrust-pc-sdk #ot-pc-content.ot-pc-scrollbar #ot-category-title,
#onetrust-pc-sdk .ot-cat-header
{
 font-weight: 500 !important;
}
#onetrust-pc-sdk .ot-acc-hdr.ot-always-active-group .ot-always-active {
 color: #003d61;
}
#onetrust-pc-sdk .ot-pc-footer-logo {
  display: none; 
}
#onetrust-pc-sdk .ot-cat-grp .ot-always-active-group .ot-always-active,
#onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
#onetrust-pc-sdk .ot-host-hdr .ot-host-name {
 font-weight: 500;
}
#onetrust-consent-sdk *:focus,
#onetrust-consent-sdk *:hover {
  opacity: 1 !important;
  outline-offset: 0 !important;
}
#ot-sdk-btn.ot-sdk-show-settings {
    appearance: none;
    border: 0.0625rem solid #007AC3 !important;
    border-radius: 0;
    background-color: transparent;
    color: #007AC3 !important;
    font-weight: 400;
}
#ot-sdk-btn.ot-sdk-show-settings:focus {
 outline: 1px solid #000;
}
#onetrust-pc-btn-handler:hover,
#onetrust-reject-all-handler:hover,
#ot-sdk-btn.ot-sdk-show-settings:hover,
#onetrust-accept-btn-handler:hover,
#accept-recommended-btn-handler:hover,
.save-preference-btn-handler.onetrust-close-btn-handler:hover {
 background-color: #003D61 !important;
    border-color: #003D61 !important;
 color: #fff !important;
}

#onetrust-banner-sdk #onetrust-policy-title {
    display: inline-block;
    max-width: calc(100% - 75px);
    padding-left: 30px;
    font-size: 1em;
    line-height: 1.5;
    padding-bottom: 10px;
}

#onetrust-banner-sdk button, #onetrust-pc-sdk button, #ot-sdk-cookie-policy button {
    margin-bottom: 0;
    font-family: inherit;
}

#onetrust-banner-sdk #onetrust-policy {
    margin-top: 10px;
}

#onetrust-banner-sdk #onetrust-button-group-parent {
  padding: 0px 30px 4px 30px;
}

#onetrust-banner-sdk .onetrust-banner-options {
    max-width: 100%;
    display: flex;
}

#onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
    font-size: 12px;
}

#onetrust-consent-sdk .otFloatingRounded {
	bottom: 3rem !important;
}

#onetrust-banner-sdk.otFloatingRounded {
    position: fixed;
    background-color: #fff;
    max-width: 400px;
    z-index: 2147483645;
    border-radius: 2.5px;
    bottom: 2em;
    font-size: 16px;
    max-height: 90%;
    overflow-y: auto;
    overflow-x: hidden;
}#onetrust-pc-sdk.otPcCenter{overflow:hidden;position:fixed;margin:0 auto;top:5%;right:0;left:0;width:40%;max-width:575px;min-width:575px;border-radius:2.5px;z-index:2147483647;background-color:#fff;-webkit-box-shadow:0px 2px 10px -3px #999;-moz-box-shadow:0px 2px 10px -3px #999;box-shadow:0px 2px 10px -3px #999}#onetrust-pc-sdk.otPcCenter[dir=rtl]{right:0;left:0}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk .ot-optout-signal{margin-top:.625rem}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-gn-venlst .ot-ven-item .ot-acc-hdr{min-height:40px}#onetrust-pc-sdk .ot-pc-header{height:39px;padding:10px 0 10px 30px;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk #ot-pc-title,#onetrust-pc-sdk #ot-category-title,#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk #ot-lst-title,#onetrust-pc-sdk .ot-ven-hdr .ot-ven-name,#onetrust-pc-sdk .ot-always-active{font-weight:bold;color:dimgray}#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:55%;font-weight:700}#onetrust-pc-sdk .ot-cat-item p{clear:both;float:left;margin-top:10px;margin-bottom:5px;line-height:1.5;font-size:.812em;color:dimgray}#onetrust-pc-sdk .ot-close-icon{height:44px;width:44px;background-size:10px}#onetrust-pc-sdk #ot-pc-title{float:left;font-size:1em;line-height:1.5;margin-bottom:10px;margin-top:10px;width:100%}#onetrust-pc-sdk #accept-recommended-btn-handler{margin-right:10px;margin-bottom:25px;outline-offset:-1px}#onetrust-pc-sdk #ot-pc-desc{clear:both;width:100%;font-size:.812em;line-height:1.5;margin-bottom:25px}#onetrust-pc-sdk #ot-pc-desc a{margin-left:5px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px}#onetrust-pc-sdk a{color:#656565;cursor:pointer}#onetrust-pc-sdk a:hover{color:#3860be}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk button{max-width:394px;padding:12px 30px;line-height:1;word-break:break-word;word-wrap:break-word;white-space:normal;font-weight:bold;height:auto}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk #ot-pc-content{position:absolute;overflow-y:scroll;padding-left:0px;padding-right:30px;top:60px;bottom:110px;margin:1px 3px 0 30px;width:calc(100% - 63px)}#onetrust-pc-sdk .ot-vs-list .ot-always-active,#onetrust-pc-sdk .ot-cat-grp .ot-always-active{float:right;clear:none;color:#3860be;margin:0;font-size:.813em;line-height:1.3}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-track{margin-right:20px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#d8d8d8}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#d8d8d8;scrollbar-darkshadow-color:#d8d8d8;scrollbar-face-color:#d8d8d8;scrollbar-shadow-color:#d8d8d8}#onetrust-pc-sdk .save-preference-btn-handler{margin-right:20px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-right:10px}#onetrust-pc-sdk #ot-pc-desc .privacy-notice-link{margin-left:0;margin-right:8px}#onetrust-pc-sdk #ot-pc-desc .ot-imprint-handler{margin-left:0;margin-right:8px}#onetrust-pc-sdk .ot-subgrp-cntr{display:inline-block;clear:both;width:100%;padding-top:15px}#onetrust-pc-sdk .ot-switch+.ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:initial}#onetrust-pc-sdk ul.ot-subgrps li p,#onetrust-pc-sdk ul.ot-subgrps li h5{font-size:.813em;line-height:1.4;color:dimgray}#onetrust-pc-sdk ul.ot-subgrps .ot-switch{min-height:auto}#onetrust-pc-sdk ul.ot-subgrps .ot-switch-nob{top:0}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr{display:inline-block;width:100%}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-txt{margin:0}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none}#onetrust-pc-sdk ul.ot-subgrps li h5{position:relative;top:5px;font-weight:bold;margin-bottom:0;float:left}#onetrust-pc-sdk li.ot-subgrp{margin-left:20px;overflow:auto}#onetrust-pc-sdk li.ot-subgrp>h5{width:calc(100% - 100px)}#onetrust-pc-sdk .ot-cat-item p>ul,#onetrust-pc-sdk li.ot-subgrp p>ul{margin:0px;list-style:disc;margin-left:15px;font-size:inherit}#onetrust-pc-sdk .ot-cat-item p>ul li,#onetrust-pc-sdk li.ot-subgrp p>ul li{font-size:inherit;padding-top:10px;padding-left:0px;padding-right:0px;border:none}#onetrust-pc-sdk .ot-cat-item p>ul li:last-child,#onetrust-pc-sdk li.ot-subgrp p>ul li:last-child{padding-bottom:10px}#onetrust-pc-sdk .ot-pc-logo{height:40px;width:120px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-refuse-all-handler{margin-bottom:0px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:160px}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{width:100%;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:0 30px;width:calc(100% - 60px);padding-right:0}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo{direction:rtl}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo a{margin-right:25px}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#cddcf2;border:1px solid #3860be}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(20px);-ms-transform:translateX(20px);transform:translateX(20px);background-color:#3860be;border-color:#3860be}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch{outline:#000 solid 1px}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:45px;height:25px}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#f2f1f1;border:1px solid #ddd;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:20px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:"";height:21px;width:21px;bottom:1px;background-color:#7d7d7d;-webkit-transition:.4s;transition:.4s;border-radius:20px}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox label{position:relative;display:inline-block;padding-left:30px;cursor:pointer;font-weight:500}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px;top:auto}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw-cntr .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-tgl-cntr,#onetrust-pc-sdk .ot-arw-cntr{display:inline-block}#onetrust-pc-sdk .ot-tgl-cntr{width:45px;float:right;margin-top:2px}#onetrust-pc-sdk #ot-lst-cnt .ot-tgl-cntr{margin-top:10px}#onetrust-pc-sdk .ot-always-active-subgroup{width:auto;padding-left:0px !important;top:3px;position:relative}#onetrust-pc-sdk .ot-label-status{padding-left:5px;font-size:.75em;display:none}#onetrust-pc-sdk .ot-arw-cntr{margin-top:-1px}#onetrust-pc-sdk .ot-arw-cntr svg{-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s;transition:all 300ms ease-in 0s;height:10px;width:10px}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-arw{width:10px;margin-left:15px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0}#onetrust-pc-sdk .ot-hlst-cntr{margin-top:5px;display:inline-block;width:100%}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{clear:both;color:#3860be;margin-left:0;font-size:.813em;text-decoration:none;float:left;overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover,#onetrust-pc-sdk .category-host-list-handler:hover{text-decoration-line:underline}#onetrust-pc-sdk .category-vendors-list-handler+a{clear:none}#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk{display:inline-block;height:13px;width:13px;background-repeat:no-repeat;margin-left:1px;margin-top:6px;cursor:pointer}#onetrust-pc-sdk .back-btn-handler{font-size:1em;text-decoration:none}#onetrust-pc-sdk .back-btn-handler:hover{opacity:.6}#onetrust-pc-sdk #ot-lst-title h3{display:inline-block;word-break:break-word;word-wrap:break-word;margin-bottom:0;color:#656565;font-size:1em;font-weight:bold;margin-left:15px}#onetrust-pc-sdk #ot-lst-title{margin:10px 0 10px 0px;font-size:1em;text-align:left}#onetrust-pc-sdk #ot-pc-hdr{margin:0 0 0 30px;height:auto;width:auto}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#d4d4d4;font-style:italic}#onetrust-pc-sdk #vendor-search-handler{height:31px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left;margin-left:15px}#onetrust-pc-sdk .ot-ven-name{display:block;width:auto;padding-right:5px}#onetrust-pc-sdk #ot-lst-cnt{overflow-y:auto;margin-left:20px;margin-right:7px;width:calc(100% - 27px);max-height:calc(100% - 80px);height:100%;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-pc-lst{width:100%;bottom:100px;position:absolute;top:60px}#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr *{visibility:hidden}#onetrust-pc-sdk #ot-pc-lst .ot-tgl-cntr{right:12px;position:absolute}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:right;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-arw{margin-left:10px}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{overflow:hidden;cursor:pointer}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk #ot-sel-blk{overflow:hidden;width:100%;position:sticky;position:-webkit-sticky;top:0;z-index:3}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk .ot-lst-subhdr{width:100%;display:inline-block}#onetrust-pc-sdk .ot-search-cntr{float:left;width:78%;position:relative}#onetrust-pc-sdk .ot-search-cntr>svg{width:30px;height:30px;position:absolute;float:left;right:-15px}#onetrust-pc-sdk .ot-fltr-cntr{float:right;right:50px;position:relative}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;display:inline-block;position:relative;width:32px;height:32px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;padding:0;margin:0}#onetrust-pc-sdk #filter-btn-handler:hover{background-color:#3860be}#onetrust-pc-sdk #filter-btn-handler svg{width:12px;height:12px;margin:3px 10px 0 10px;display:block;position:static;right:auto;top:auto}#onetrust-pc-sdk .ot-ven-link{color:#3860be;text-decoration:none;font-weight:100;display:inline-block;padding-top:10px;transform:translate(0, 1%);-o-transform:translate(0, 1%);-ms-transform:translate(0, 1%);-webkit-transform:translate(0, 1%);position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:calc(100% - 160px);height:auto;float:left;word-break:break-word;word-wrap:break-word;vertical-align:middle;padding-bottom:3px}#onetrust-pc-sdk .ot-ven-link{letter-spacing:.03em;font-size:.75em;font-weight:400}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #ddd !important}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h4{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h4{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-last-child(-n+1){padding-bottom:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-child(-n+2):not(.disc-pur){padding-top:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur-cont{display:inline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur{position:relative;width:50% !important;word-break:break-word;word-wrap:break-word;left:calc(30% + 17px)}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur:nth-child(-n+1){position:static}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h4,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h4{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h4{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk #ot-host-lst .ot-sel-all{float:right;position:relative;margin-right:42px;top:10px}#onetrust-pc-sdk #ot-host-lst .ot-sel-all input[type=checkbox]{width:auto;height:auto}#onetrust-pc-sdk #ot-host-lst .ot-sel-all label{height:20px;width:20px;padding-left:0px}#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{overflow:hidden;width:95%}#onetrust-pc-sdk .ot-host-hdr{position:relative;z-index:1;pointer-events:none;width:calc(100% - 125px);float:left}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-desc{display:inline-block;width:90%}#onetrust-pc-sdk .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr>a{text-decoration:underline;font-size:.82em;position:relative;z-index:2;float:left;margin-bottom:5px;pointer-events:initial}#onetrust-pc-sdk .ot-host-name+a{margin-top:5px}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a,#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{color:dimgray;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a{font-weight:bold;font-size:.82em;line-height:1.3}#onetrust-pc-sdk .ot-host-name a{font-size:1em}#onetrust-pc-sdk .ot-host-expand{margin-top:3px;margin-bottom:3px;clear:both;display:block;color:#3860be;font-size:.72em;font-weight:normal}#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{font-size:.688em;line-height:1.4;font-weight:normal}#onetrust-pc-sdk .ot-host-desc{margin-top:10px}#onetrust-pc-sdk .ot-host-opt{margin:0;font-size:inherit;display:inline-block;width:100%}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.8em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-info{border:none;display:inline-block;width:calc(100% - 10px);padding:10px;margin-bottom:10px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk #ot-fltr-modal{width:100%;height:auto;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;overflow:hidden;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal .ot-label-txt{display:inline-block;font-size:.85em;color:dimgray}#onetrust-pc-sdk #ot-fltr-cnt{z-index:2147483646;background-color:#fff;position:absolute;height:90%;max-height:300px;width:325px;left:210px;margin-top:10px;margin-bottom:20px;padding-right:10px;border-radius:3px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk #ot-anchor{border:12px solid transparent;display:none;position:absolute;z-index:2147483647;right:55px;top:75px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-btns{margin-left:15px}#onetrust-pc-sdk #filter-apply-handler{margin-right:15px}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:25px;margin-left:15px;width:75%;position:relative}#onetrust-pc-sdk .ot-fltr-opt p{display:inline-block;margin:0;font-size:.9em;color:#2e3644}#onetrust-pc-sdk .ot-chkbox label span{font-size:.85em;color:dimgray}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-hostcntr,#onetrust-pc-sdk #ot-selall-licntr,#onetrust-pc-sdk #ot-selall-gnvencntr{right:15px;position:relative;width:20px;height:20px;float:right}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label,#onetrust-pc-sdk #ot-selall-gnvencntr label{float:left;padding-left:0}#onetrust-pc-sdk #ot-ven-lst:first-child{border-top:1px solid #e2e2e2}#onetrust-pc-sdk ul{list-style:none;padding:0}#onetrust-pc-sdk ul li{position:relative;margin:0;padding:15px 15px 15px 10px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk ul li h3{font-size:.75em;color:#656565;margin:0;display:inline-block;width:70%;height:auto;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul li p{margin:0;font-size:.7em}#onetrust-pc-sdk ul li input[type=checkbox]{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-cat-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus,#onetrust-pc-sdk li>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-cat-item>button,#onetrust-pc-sdk .ot-acc-cntr>button,#onetrust-pc-sdk li>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-ven-item>button:focus{outline:0;border:2px solid #000}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-plus-minus>*,#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk .ot-hide-acc .ot-acc-hdr{min-height:30px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt){padding-right:10px;width:calc(100% - 37px);margin-top:10px;max-height:calc(100% - 90px)}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:calc(100% - 2px);padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt{border:unset;background-color:unset}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all-hdr{display:none}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all{padding-right:.5rem}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all .ot-chkbox{right:0}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all{padding-right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{width:auto}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) ul li{border:1px solid #e2e2e2;margin-bottom:10px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-acc-cntr>.ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk.ot-addtl-vendors .ot-sel-all-chkbox{float:right}#onetrust-pc-sdk.ot-addtl-vendors .ot-plus-minus~.ot-sel-all-chkbox{right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-ven-lst:first-child{border-top:none}#onetrust-pc-sdk .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr{background-color:#f9f9fc;padding:5px 0 5px 15px;width:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-plus-minus{vertical-align:middle;top:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-arw-cntr{right:10px}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk .ot-acc-cntr.ot-add-tech .ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-txt{padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-acc-cntr button[aria-expanded=true]~.ot-acc-txt{width:auto}#onetrust-pc-sdk .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0;width:100%}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;vertical-align:middle;display:inline-block}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{margin-left:0;margin-top:10px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none;left:5px;top:9px}#onetrust-pc-sdk #ot-category-title{float:left;padding-bottom:10px;font-size:1em;width:100%}#onetrust-pc-sdk .ot-cat-grp{margin-top:10px}#onetrust-pc-sdk .ot-cat-item{line-height:1.1;margin-top:10px;display:inline-block;width:100%}#onetrust-pc-sdk .ot-btn-container{text-align:right}#onetrust-pc-sdk .ot-btn-container button{display:inline-block;font-size:.75em;letter-spacing:.08em;margin-top:19px}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{position:absolute;top:10px;right:0;z-index:1;padding:0;background-color:transparent;border:none}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon svg{display:block;height:10px;width:10px}#onetrust-pc-sdk #clear-filters-handler{margin-top:20px;margin-bottom:10px;float:right;max-width:200px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:transparent;border-color:transparent;padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#2285f7}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl,#onetrust-pc-sdk .ot-enbl-chr h4~.ot-always-active{right:45px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl+.ot-tgl{right:120px}#onetrust-pc-sdk .ot-enbl-chr .ot-pli-hdr.ot-leg-border-color span:first-child{width:90px}#onetrust-pc-sdk .ot-enbl-chr li.ot-subgrp>h5+.ot-tgl-cntr{padding-right:25px}#onetrust-pc-sdk .ot-plus-minus{width:20px;height:20px;font-size:1.5em;position:relative;display:inline-block;margin-right:5px;top:3px}#onetrust-pc-sdk .ot-plus-minus span{position:absolute;background:#27455c;border-radius:1px}#onetrust-pc-sdk .ot-plus-minus span:first-of-type{top:25%;bottom:25%;width:10%;left:45%}#onetrust-pc-sdk .ot-plus-minus span:last-of-type{left:25%;right:25%;height:10%;top:45%}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:first-of-type,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{transform:rotate(90deg)}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{left:50%;right:50%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk .ot-host-item .ot-plus-minus,#onetrust-pc-sdk .ot-ven-item .ot-plus-minus{float:left;margin-right:8px;top:10px}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-pli-hdr{color:#77808e;overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;width:calc(100% - 2px);border-top-left-radius:3px;border-top-right-radius:3px}#onetrust-pc-sdk .ot-pli-hdr span:first-child{top:50%;transform:translateY(50%);max-width:90px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:10px;max-width:95px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color{background-color:#f4f4f4;border:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color span:first-child{text-align:left;width:70px}#onetrust-pc-sdk li.ot-subgrp>h5,#onetrust-pc-sdk .ot-cat-header{width:calc(100% - 130px)}#onetrust-pc-sdk li.ot-subgrp>h5+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-acc-grpdesc{margin-bottom:5px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-acc-grpcntr .ot-vlst-cntr+.ot-subgrp-cntr{border-top:none}#onetrust-pc-sdk .ot-acc-hdr .ot-arw-cntr+.ot-tgl-cntr,#onetrust-pc-sdk .ot-acc-txt h4+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-subgrp>h5,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header{width:calc(100% - 145px)}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item h5+.ot-tgl-cntr,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header+.ot-tgl{padding-left:28px}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{display:inline-block;width:100%;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk .ot-sel-all{margin:0;position:relative;padding-right:23px;float:right}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;padding-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:auto;float:right;position:relative;right:80px}#onetrust-pc-sdk #ot-selall-licntr label{position:absolute}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:66px}#onetrust-pc-sdk .ot-ven-litgl+.ot-arw-cntr{margin-left:81px}#onetrust-pc-sdk .ot-enbl-chr .ot-host-cnt .ot-tgl-cntr{width:auto}#onetrust-pc-sdk #ot-lst-cnt:not(.ot-host-cnt) .ot-tgl-cntr{width:auto;top:auto;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox label{position:absolute;padding:0;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-acc-grpdesc+.ot-leg-btn-container{padding-left:20px;padding-right:20px;width:calc(100% - 40px);margin-bottom:5px}#onetrust-pc-sdk .ot-subgrp .ot-leg-btn-container{margin-bottom:5px}#onetrust-pc-sdk #ot-ven-lst .ot-leg-btn-container{margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;letter-spacing:0;font-size:.75em;line-height:normal}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{text-decoration:underline;padding:0;font-size:.75em;font-weight:600;line-height:1;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:inherit;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;right:15px;top:15px;width:auto;font-weight:normal}#onetrust-pc-sdk .ot-cat-header{float:left;font-weight:600;font-size:.875em;line-height:1.5;max-width:90%;vertical-align:middle}#onetrust-pc-sdk .ot-vnd-item>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-vnd-item>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{position:relative;border-radius:2px;margin:0;padding:0;border:1px solid #d8d8d8;border-top:none;width:calc(100% - 2px);float:left}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{margin-top:10px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc{padding-left:20px;padding-right:20px;width:calc(100% - 40px);font-size:.812em;margin-bottom:10px;margin-top:15px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul{padding-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul li{padding-top:0;line-height:1.5;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout div+.ot-acc-grpdesc{margin-top:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:first-child{margin-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:last-child,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr:last-child{margin-bottom:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding-top:11.5px;padding-bottom:11.5px;padding-left:20px;padding-right:20px;width:calc(100% - 40px);display:inline-block}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-txt{width:100%;padding:0}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp-cntr{padding-left:20px;padding-right:15px;padding-bottom:0;width:calc(100% - 35px)}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp{padding-right:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpcntr{z-index:1;position:relative}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr{position:absolute;top:50%;transform:translateY(-50%);right:20px;margin-top:-2px}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr .ot-arw{width:15px;height:20px;margin-left:5px;color:dimgray}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{float:none;color:#2e3644;margin:0;display:inline-block;height:auto;word-wrap:break-word;min-height:inherit}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding-left:20px;width:calc(100% - 20px);display:inline-block;margin-top:0;padding-bottom:2px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{position:relative;min-height:25px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl,#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{position:absolute;top:50%;transform:translateY(-50%);right:20px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl+.ot-tgl{right:95px}#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler,#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler+a{margin-top:5px}#onetrust-pc-sdk #ot-lst-cnt{margin-top:1rem;max-height:calc(100% - 96px)}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list,#onetrust-pc-sdk .ot-vnd-serv{width:auto;padding:1rem 1.25rem;padding-bottom:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:600;font-size:.95em;line-height:2;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item{border:none;margin:0;padding:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button{outline:none;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button[aria-expanded=true],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button[aria-expanded=true]{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:first-child{margin-top:.25rem;border-top:unset}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child{margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child button{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 1.75rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-lbl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-cnt,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt{padding-left:40px}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-size:.8em}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-cat-header{font-size:.8em}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv{margin-bottom:1rem;padding:1rem .95rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:700;font-size:.8em;line-height:20px;margin-left:.82rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-cat-header{font-weight:700;font-size:.8em;line-height:20px}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-vnd-serv .ot-vnd-lst-cont .ot-accordion-layout .ot-acc-hdr div.ot-chkbox{margin-left:.82rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr{padding:.5rem 0;margin:0;display:flex;width:100%;align-items:center;justify-content:space-between}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:first-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:first-child{margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:last-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:last-child{margin-right:.5rem;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-always-active{position:relative;right:unset;top:unset;transform:unset}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-plus-minus{top:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-arw-cntr{float:none;top:unset;right:unset;transform:unset;margin-top:-2px;position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-cat-header{flex:1;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-tgl{position:relative;transform:none;right:0;top:0;float:none}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox{position:relative;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label{padding:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label::before{position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox input{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0;z-index:1}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h5.ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h4.ot-cat-header{margin:0}#onetrust-pc-sdk .ot-vs-config .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp h5{top:0;line-height:20px}#onetrust-pc-sdk .ot-vs-list{display:flex;flex-direction:column;padding:0;margin:.5rem 4px}#onetrust-pc-sdk .ot-vs-selc-all{display:flex;padding:0;float:unset;align-items:center;justify-content:flex-start}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf{justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:48px}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{margin:0;padding:0;margin-right:14px;justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-chkbox,#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-tgl{display:inline-block;right:unset;width:auto;height:auto;float:none}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:45px;height:25px}#onetrust-pc-sdk .ot-vs-selc-all .ot-sel-all-chkbox{margin-right:11px;margin-left:.75rem;display:flex;align-items:center}#onetrust-pc-sdk .ot-vs-selc-all .sel-all-hdr{margin:0 1.25rem;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-vnd-list-cnt #ot-selall-vencntr.ot-chkbox{float:unset;right:0}#onetrust-pc-sdk[dir=rtl] #ot-back-arw,#onetrust-pc-sdk[dir=rtl] input~.ot-acc-hdr .ot-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk[dir=rtl] .ot-search-cntr>svg{right:0}@media only screen and (max-width: 600px){#onetrust-pc-sdk.otPcCenter{left:0;min-width:100%;height:100%;top:0;border-radius:0}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:1px 3px 0 10px;padding-right:10px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-btn-container button{max-width:none;letter-spacing:.01em}#onetrust-pc-sdk #close-pc-btn-handler{top:10px;right:17px}#onetrust-pc-sdk p{font-size:.7em}#onetrust-pc-sdk #ot-pc-hdr{margin:10px 10px 0 5px;width:calc(100% - 15px)}#onetrust-pc-sdk .vendor-search-handler{font-size:1em}#onetrust-pc-sdk #ot-back-arw{margin-left:12px}#onetrust-pc-sdk #ot-lst-cnt{margin:0;padding:0 5px 0 10px;min-width:95%}#onetrust-pc-sdk .switch+p{max-width:80%}#onetrust-pc-sdk .ot-ftr-stacked button{width:100%}#onetrust-pc-sdk #ot-fltr-cnt{max-width:320px;width:90%;border-top-right-radius:0;border-bottom-right-radius:0;margin:0;margin-left:15px;left:auto;right:40px;top:85px}#onetrust-pc-sdk .ot-fltr-opt{margin-left:25px;margin-bottom:10px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-bottom:0}#onetrust-pc-sdk #ot-fltr-cnt{right:40px}}@media only screen and (max-width: 476px){#onetrust-pc-sdk .ot-fltr-cntr,#onetrust-pc-sdk #ot-fltr-cnt{right:10px}#onetrust-pc-sdk #ot-anchor{right:25px}#onetrust-pc-sdk button{width:100%}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-sel-all{padding-right:9px}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr{right:0}}@media only screen and (max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk.otPcCenter{left:0;top:0;min-width:100%;height:100%;border-radius:0}#onetrust-pc-sdk #ot-anchor{left:initial;right:50px}#onetrust-pc-sdk #ot-lst-title{margin-top:12px}#onetrust-pc-sdk #ot-lst-title *{font-size:inherit}#onetrust-pc-sdk #ot-pc-hdr input{margin-right:0;padding-right:45px}#onetrust-pc-sdk .switch+p{max-width:85%}#onetrust-pc-sdk #ot-sel-blk{position:static}#onetrust-pc-sdk #ot-pc-lst{overflow:auto}#onetrust-pc-sdk #ot-lst-cnt{max-height:none;overflow:initial}#onetrust-pc-sdk #ot-lst-cnt.no-results{height:auto}#onetrust-pc-sdk input{font-size:1em !important}#onetrust-pc-sdk p{font-size:.6em}#onetrust-pc-sdk #ot-fltr-modal{width:100%;top:0}#onetrust-pc-sdk ul li p,#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{font-size:.6em}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{height:100% !important;overflow:hidden;top:0px}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-cnt{margin:0;height:100%;max-height:none;padding:10px;top:0;width:calc(100% - 20px);position:absolute;right:0;left:0;max-width:none}#onetrust-pc-sdk.ot-shw-fltr .ot-fltr-scrlcnt{max-height:calc(100% - 65px)}}
            #onetrust-consent-sdk #onetrust-pc-sdk,
                #onetrust-consent-sdk #ot-search-cntr,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,
                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after
                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {
                    background-color: #FFFFFF;
                }
               
            #onetrust-consent-sdk #onetrust-pc-sdk h3,
                #onetrust-consent-sdk #onetrust-pc-sdk h4,
                #onetrust-consent-sdk #onetrust-pc-sdk h5,
                #onetrust-consent-sdk #onetrust-pc-sdk h6,
                #onetrust-consent-sdk #onetrust-pc-sdk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-optout-signal
                {
                    color: #232323;
                }
             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info a
                    {
                        color: #007AC3;
                    }
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { text-decoration: underline;}
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle
             {
                background-color: #ededed;
            }
             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets
                            {
                                background-color: #ededed;
                            }
        #onetrust-consent-sdk #onetrust-pc-sdk
            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {
                background-color: #007AC3;border-color: #007AC3;
                color: #FFFFFF;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                border-color: #007AC3;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{
                background-color: transparent;
                border: 1px solid transparent;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {
                background-color: #FFFFFF;
                color: #78808E; border-color: #78808E;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,
            #onetrust-pc-sdk .ot-checkbox input[type="checkbox"]:focus + label::before,
            #onetrust-pc-sdk .ot-chkbox input[type="checkbox"]:focus + label::before {
                outline-color: #000000;
                outline-width: 1px;
            }
            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {
                border: 1px solid #000000;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {
               outline: 1px solid #000000;
            }#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk {
                    background-image: url('https://cdn.cookielaw.org/logos/static/ot_external_link.svg');
                }
            #onetrust-pc-sdk .ot-sdk-row {padding: 0;}

#onetrust-pc-sdk .ot-switch-nob {
    background-color: #cddcf2;
    border: 1px solid #3860be;
    font-size: 0px;
}

#onetrust-pc-sdk .ot-switch-nob:before {
    position: absolute;
    content: "";
    height: 21px;
    width: 21px;
    bottom: 0px;
    background-color: #7d7d7d;
    -webkit-transition: .4s;
    transition: .4s;
    border-radius: 20px;
}

#onetrust-pc-sdk .ot-cat-grp {
    margin-top: 10px;
    margin-bottom: 10px;
}

#onetrust-pc-sdk #ot-pc-desc {
font-size: 12px;
line-height: 1.5;
}

#onetrust-pc-sdk #ot-pc-title {
    float: left;
    font-size: 1.25em;
    line-height: 1.5;
    margin-bottom: 10px;
    margin-top: 10px;
    width: 100%;
}

#onetrust-pc-sdk #ot-category-title {
    float: left;
    padding-bottom: 10px;
    font-size: 18px;
    width: 100%;
}

#onetrust-pc-sdk .ot-cat-header {
    float: left;
    font-weight: 600;
    font-size: 14px;
    line-height: 1.5;
    max-width: 90%;
    vertical-align: middle;
}

#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc {
    padding-left: 20px;
    padding-right: 20px;
    width: calc(100% - 40px);
    font-size: 12px;
    margin-bottom: 10px;
    margin-top: 15px;
}

#onetrust-pc-sdk .category-vendors-list-handler, #onetrust-pc-sdk .category-vendors-list-handler+a, #onetrust-pc-sdk .category-host-list-handler {
    clear: both;
    color: #3860be;
    margin-left: 0;
    font-size: 14px;
    text-decoration: none;
    float: left;
    overflow: hidden;
}

#onetrust-pc-sdk .ot-btn-container button {
    display: inline-block;
    font-size: 14px;
    letter-spacing: .08em;
    margin-top: 19px;
	margin-bottom: 15px
}.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}
                
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {
                        color: #232323;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {
                        color: #232323;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {
                        color: #232323;
                    }
                    
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {
                            color: #232323;
                        }
                    
            
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {
                            background-color: #ededed;
                        }
                    
            .ot-floating-button__front{background-image:url('https://cdn.cookielaw.org/logos/static/ot_persistent_cookie.png')}
                      @keyframes slide-down-custom {
                          0% {
                              bottom: 993px !important;
                          }
                          100% {
                              bottom: 1em;
                          }
                      }
                      @-webkit-keyframes slide-down-custom {
                          0% {
                              bottom: 993px !important;
                          }
                          100% {
                              bottom: 1em;
                          }
                      }
                      @-moz-keyframes slide-down-custom {
                          0% {
                              bottom: 993px !important;
                          }
                          100% {
                              bottom: 1em;
                          }
                      }
                      </style><script type="text/plain" src="https://www.googletagmanager.com/gtm.js?id=" class="optanon-category-C0002 "></script></head>

<body class="ds1-utd-js textSize-M ChromiumProject isDesktop  linux vueLoaded utd-logo en NONE hasSessionData anonymous-user topicPrint topicView fullWidth utdRoute-topicLanguagePrint">
  <div id="appContainer" data-v-app=""><div id="paceHolder"><div class="pace pace-inactive"><div class="pace-progress" data-progress-text="100%" data-progress="99" style="transform: translate3d(100%, 0px, 0px);">
  <div class="pace-progress-inner"></div>
</div>
<div class="pace-activity"></div></div></div> <header><!----> <section data-v-012a7bd6="" id="prospect-login-register-header-section"><header data-v-012a7bd6="" class="wk-header" role="banner"><div data-v-012a7bd6="" class="wk-header-container"><div data-v-012a7bd6="" class=""><a class="wk-logo" role="link" aria-label="UpToDate logo" href="/contents/search" tabindex="0"><img src="/app/utd-menu/wk-wheel-icon.svg" class="wk-wheel" alt="Wolters Kluwer"><img src="/app/utd-menu/utd-logo.svg" class="utd-logo" alt="UpToDate"></a> <!----></div> <div data-v-cfd16534="" data-v-012a7bd6="" data-utd-content-searchbar=""><div data-v-cfd16534="" id="search-combobox" class="search-bar-ac-unit" role="combobox" aria-haspopup="listbox" aria-owns="search-listbox" aria-expanded="false"><div data-v-cfd16534="" class="search-bar-container"><button data-v-cfd16534="" class="search-bar-left automation_searchBarMobileBackBtn"></button><div data-v-cfd16534="" class="search-bar"><form data-v-cfd16534="" role="search" name="searchForm" aria-label="Sitewide" novalidate=""><span data-v-cfd16534="" class="search-icon"></span> <div data-v-cfd16534="" class="utdBarSearchCtrlContainer"><input data-v-cfd16534="" id="tbSearch" type="search" spellcheck="false" role="combobox" class="utdBarSearchCtrl term searchTerm" placeholder="Search UpToDate" data-autocorrect="off" aria-labelledby="search-uptodate" aria-expanded="false" aria-controls="search-listbox" aria-autocomplete="list" data-autocapitalize="off" autocomplete="off" aria-activedescendant="" autocapitalize="off" autocorrect="off" required="" value=""></div> <span data-v-cfd16534="" class="search-clear" tabindex="0" role="button" aria-label="Clear the input" id="clearSearch" aria-expanded="false" style="display: none;"><i class="fa fa-times-circle"></i></span> <input data-v-cfd16534="" id="searchControl" type="hidden" name="searchControl" value="TOP_PULLDOWN"> <input data-v-cfd16534="" id="source" type="hidden" name="source" value="USER_INPUT"> <input data-v-cfd16534="" id="searchType" type="hidden" name="searchType" value="PLAIN_TEXT"> <span data-v-cfd16534="" class="newsearch-submit" tabindex="0" role="button" aria-label="Submit search"></span></form></div><a data-v-cfd16534="" href="/contents/search" class="search-bar-right"><span data-v-cfd16534="" class="utd-menu-icon"></span></a></div> <div data-v-bfceeadc="" data-v-cfd16534="" class="autocomplete ds1-utd-font" style="display: none;"><ul data-v-bfceeadc="" id="search-listbox" class="autocomplete-ul" role="listbox" aria-labelledby="search-uptodate"></ul></div></div></div> <ul data-v-012a7bd6="" class="wk-nav" role="menu"><li data-v-012a7bd6="" role="menuitem"><a data-v-e300e72a="" data-v-012a7bd6="" href="/store" class="utd-button utd-button-link utd-button-size-small utd-button-color-green-shade-3 utd-button-style-default" role="button" track="enabled"><!----> <span data-v-e300e72a="" class="utd-button-link-text">Subscribe</span> <!----></a></li> <li data-v-012a7bd6="" role="menuitem"><a data-v-e300e72a="" data-v-012a7bd6="" href="/login" class="utd-button utd-button-link utd-button-size-small utd-button-color-blue utd-button-style-default" role="button"><!----> <span data-v-e300e72a="" class="utd-button-link-text">Sign in</span> <!----></a></li> <li data-v-012a7bd6="" role="menuitem"><div data-v-012a7bd6="" class="wk-dropdown wk-dropdown-onclick"><a data-v-012a7bd6="" id="prospect-language-selector" aria-haspopup="true" role="combobox" tabindex="0" aria-expanded="false" aria-labelledby="prospect-language-selector" aria-controls="prospect-language-selector" class="wk-dropdown-toggle">English</a> <div data-v-012a7bd6="" aria-hidden="true" aria-label="submenu" aria-expanded="false" aria-labelledby="prospect-language-selector" class="wk-language-dropdown-menu" style="display: none;"><ul data-v-012a7bd6="" role="listbox"><li data-v-012a7bd6="" role="option"><a data-v-012a7bd6="" href="#" tabindex="0">Deutsch</a></li><li data-v-012a7bd6="" role="option"><a data-v-012a7bd6="" href="#" tabindex="0">Español</a></li><li data-v-012a7bd6="" role="option"><a data-v-012a7bd6="" href="#" tabindex="0">日本語</a></li><li data-v-012a7bd6="" role="option"><a data-v-012a7bd6="" href="#" tabindex="0">Português</a></li></ul></div></div></li></ul></div></header> <nav data-v-012a7bd6="" class="wk-navbar" role="navigation"><div data-v-012a7bd6="" class="wk-navbar-container"><ul data-v-012a7bd6="" class="wk-nav" role="menu"><li data-v-012a7bd6="" role="menuitem"><a data-v-012a7bd6="" href="/home/why-uptodate">Why UpToDate?</a></li> <li data-v-012a7bd6="" role="menuitem"><a data-v-012a7bd6="" href="/home/product">Product</a></li> <li data-v-012a7bd6="" role="menuitem"><a data-v-012a7bd6="" href="/home/editorial">Editorial</a></li> <li data-v-012a7bd6="" role="menuitem"><a data-v-012a7bd6="" href="/home/subscription-options">Subscription Options</a></li></ul></div></nav> <!----></section></header> <!----> <div id="utd-main" class="utd-content-main"><div data-v-8430aa75=""><div data-v-8430aa75="" id="topicContainer" class="topicContainer tl-zh-Hans topic-type-medical topic-subtype- topic-ready outline-hidden topicTab" lang="zh-Hans"><div data-v-5566ff36="" data-v-8430aa75="" id="topic-toolbar" class="topic-toolbar toolbar-tabs-collapsed toolbar-variant-tabbed"><div data-v-5566ff36="" class="topic-toolbar-default"><!----> <!----> <div data-v-5566ff36="" id="topic-title" title="跨性别女性的评估和管理" class="topicToolbarTitle title-variant-tabbed" style="margin-right: 0px;">跨性别女性的评估和管理</div></div> <!----> <!----> <div data-v-5566ff36="" id="topic-tools" class=""><ul data-v-5566ff36=""><li data-v-5566ff36="" id="liOutlineToggle" style="display: none;"><a data-v-5566ff36="" id="toggleOutline">View Topic</a></li> <li data-v-5566ff36="" class="hoverTooltip" aria-label="Translation Feedback Instructions" style="display: none;"><a data-v-5566ff36="" aria-label="Translation Feedback Instructions" class="topic-toolbar__translation-feedback" tabindex="0"><span data-v-5566ff36="" class="wkce-icon-book-open"></span></a></li> <li data-v-5566ff36="" class="hoverTooltip" aria-label="Find in topic" style="display: none;"><a data-v-5566ff36="" aria-label="Find in topic" role="button" tabindex="0"><span data-v-5566ff36="" class="wkce-icon-fit"></span></a></li> <li data-v-5566ff36="" class="automation_toolbar-inline-cme toolbar-inline-cme" style="display: none;"><button data-v-61ac311c="" data-v-5566ff36="" class="wkce-icon-check-circle inline-cme-button hoverTooltip" tabindex="0" aria-label="Reflect on credits for CME"><div data-v-61ac311c="" class="visuallyHidden"><div data-v-61ac311c="" class="wk-js2 inline-reflection-tooltip-box"><!----> <div data-v-61ac311c="" class="inline-cme-spinner ds1-ma-2"><span data-v-61ac311c="" class="wkce-icon-filled-spinner-alt wk-spin ds1-ma-1"></span> <span data-v-61ac311c="">Loading...</span></div> <!----></div></div></button></li> <li data-v-5566ff36="" id="topicPrint" aria-label="Print" class="topicPrint mobileOverflow hoverTooltip" style="display: none;"><a data-v-5566ff36="" id="printTopic" tabindex="0" aria-label="Print" target="_blank" rel="noopener" href="/contents/zh-Hans/transgender-women-evaluation-and-management/print/print"><span data-v-5566ff36="" class="wkce-icon-print"></span></a></li> <li data-v-5566ff36="" id="topicShare" aria-label="Share" class="mobileOverflow hoverTooltip" style="display: none;"><div data-v-dbcb4c02="" data-v-5566ff36="" class="shareRoot"><a data-v-dbcb4c02="" id="shareTopic" tabindex="0" role="button" aria-label="Share"><span data-v-dbcb4c02="" class="wkce-icon-share"></span> <span data-v-dbcb4c02="" class="toolbarText">Share</span></a> </div></li> <li data-v-5566ff36="" id="topicFormulary" aria-label="Formulary" class="topic-formulary hoverTooltip" style="display: none;"><a data-v-5566ff36="" tabindex="0"><span data-v-5566ff36="" class="wk-icon-medicine"></span></a></li> <li data-v-5566ff36="" id="topicFontSize" aria-label="FontSize" class="mobileOverflow topicFontSize" style="display: none;"><div data-v-190c1992="" data-v-5566ff36="" id="fontSize"><a data-v-190c1992="" class="desktopFontIcon" aria-label="Font Size" role="button" tabindex="0" href="javascript:void(0)"></a> <nav data-v-190c1992="" style="display: none; position: fixed; top: 1px; left: 0px;"><span data-v-190c1992="">Font Size</span> <ul data-v-190c1992=""><li data-v-190c1992="" class="wk-icon-filled-check"><a data-v-190c1992="" tabindex="0" aria-label="Small" href="javascript:void(0)" aria-selected="false">Small</a></li> <li data-v-190c1992="" class="wk-icon-filled-check selected"><a data-v-190c1992="" tabindex="0" aria-label="Normal" aria-selected="true" href="javascript:void(0)">Normal</a></li> <li data-v-190c1992="" class="wk-icon-filled-check"><a data-v-190c1992="" tabindex="0" aria-label="Large" href="javascript:void(0)" aria-selected="false">Large</a></li></ul></nav></div></li> <li data-v-5566ff36="" id="bookmarkTopic" aria-label="Bookmark" class="liBookmark hoverTooltip" style="display: none;"><div data-v-b9af470f="" data-v-5566ff36="" class="utd-bookmark"><button data-v-e300e72a="" data-v-b9af470f="" class="utd-button utd-button-size-small utd-button-color-blue utd-button-style-text utd-button-icon-left bookmark-control" role="button" aria-pressed="false" aria-label="Bookmark" id="tpcBookmark"><span data-v-e300e72a="" class="utd-button-icon wkce-icon-bookmark" aria-hidden="true"></span><span data-v-b9af470f="" class="toolbarText">Bookmark</span><!----></button></div></li> <li data-v-6658d8da="" data-v-5566ff36="" class="toolbar_rateTopic" style="display: none;"><div data-v-6658d8da="" class="toolbar-menu__container"><div data-v-6658d8da="" class="toolbar-menu__item"><span data-v-5566ff36="" aria-hidden="true" class="wkce-icon-star"></span> <span data-v-5566ff36="" class="rateLabel" aria-label="Rate this topic">Rate</span></div> <div data-v-6658d8da="" class="toolbar-menu__drawer" style="display: none; position: fixed; top: 1px; left: 0px;"> <div data-v-8cd9fe1d="" data-v-5566ff36="" class="star-rating__container utdStarRating_topicMobile star-rating-wide" aria-labelledby="rating-label-wkutdComponentId_57" id="mobileTopicStarRating"><!----> <ul data-v-8cd9fe1d="" class="star-rating" role="radiogroup"><li data-v-8cd9fe1d="" aria-checked="false" aria-label="1 star" class="rating-list wkce-icon-star" role="radio" tabindex="0"></li><li data-v-8cd9fe1d="" aria-checked="false" aria-label="2 stars" class="rating-list wkce-icon-star" role="radio" tabindex="0"></li><li data-v-8cd9fe1d="" aria-checked="false" aria-label="3 stars" class="rating-list wkce-icon-star" role="radio" tabindex="0"></li><li data-v-8cd9fe1d="" aria-checked="false" aria-label="4 stars" class="rating-list wkce-icon-star" role="radio" tabindex="0"></li><li data-v-8cd9fe1d="" aria-checked="false" aria-label="5 stars" class="rating-list wkce-icon-star" role="radio" tabindex="0"></li></ul></div></div></div></li> <li data-v-5566ff36="" aria-label="Provide Feedback" class="mobileOverflow" style="display: none;"><div data-v-2f951855="" data-v-5566ff36=""> <div data-v-2f951855="" style="display: none;"></div> <a data-v-2f951855="" class="topic-feedback-button" tabindex="0" aria-label="Provide Topic Feedback"><span data-v-2f951855="" class="wkce-icon-chat-box"></span> <span data-v-2f951855="" class="topic-feedback-button-text">Feedback</span></a></div></li> <li data-v-5566ff36="" id="toolsMenu" class=""><a data-v-5566ff36="">Tools</a></li></ul></div> <!----> <div data-v-46bce16e="" data-v-5566ff36="" class="utd-push-notification ds1-pa-2 med-topic-formulink-push-notification" style="display: none;"><div data-v-46bce16e="" class="utd-push-notification-close-btn wkce-icon-close"></div> <div data-v-46bce16e="" class="utd-push-notification-header ds1-mb-2 ds1-pr-4">Formulary drug information for this topic</div> <div data-v-46bce16e="" class="utd-push-notification-body"><i data-v-5566ff36="" class="wk-icon-info"></i><span data-v-5566ff36="">No drug references linked in this topic.</span></div></div> <!----></div> <!----> <div data-v-54d0e4b0="" data-v-8430aa75="" id="overflowTopicDropdown" class="overflowTopicDropdown" style="display: none; position: fixed; top: 1px; left: 0px;"><ul data-v-54d0e4b0=""><li data-v-54d0e4b0="" class="topoverflowTopicDropdown"></li> <li data-v-54d0e4b0="" class="mobileOverflow" style="display: none;"><a data-v-54d0e4b0="">Find in topic</a></li> <!----> <li data-v-54d0e4b0="" id="topicFormularyMobile" class="mobileOverflow menuItem" style="display: none;"><a data-v-54d0e4b0="">Formulary</a></li> <li data-v-54d0e4b0="" id="topicPrint" class="mobileOverflow" style="display: none;"><a data-v-54d0e4b0="" id="printTopic" target="_blank" rel="noopener" href="/contents/zh-Hans/transgender-women-evaluation-and-management/print/print">Print</a></li> <li data-v-54d0e4b0="" id="topicShare" class="mobileOverflow" style="display: none;"><div data-v-dbcb4c02="" data-v-54d0e4b0="" class="shareRoot"><a data-v-dbcb4c02="" id="shareTopic" tabindex="0" role="button" aria-label="Share"><span data-v-dbcb4c02="" class="wkce-icon-share"></span> <span data-v-dbcb4c02="" class="toolbarText">Share</span></a> </div></li> <li data-v-54d0e4b0="" aria-label="Provide Feedback" class="mobileOverflow" style="display: none;"><div data-v-2f951855="" data-v-54d0e4b0=""> <div data-v-2f951855="" style="display: none;"></div> <a data-v-2f951855="" class="topic-feedback-button" tabindex="0" aria-label="Provide Topic Feedback"><!----> <span data-v-2f951855="" class="topic-feedback-button-text">Feedback</span></a></div></li> <li data-v-54d0e4b0="" id="topicFontSize" class="mobileOverflow topicFontSize" style="display: none;"><div data-v-190c1992="" data-v-54d0e4b0="" id="fontSize"><a data-v-190c1992="" class="desktopFontIcon" aria-label="Font Size" role="button" tabindex="0" href="javascript:void(0)"></a> <nav data-v-190c1992="" style="display: none; position: fixed; top: 1px; left: 0px;"><span data-v-190c1992="">Font Size</span> <ul data-v-190c1992=""><li data-v-190c1992="" class="wk-icon-filled-check"><a data-v-190c1992="" tabindex="0" aria-label="Small" href="javascript:void(0)" aria-selected="false">Small</a></li> <li data-v-190c1992="" class="wk-icon-filled-check selected"><a data-v-190c1992="" tabindex="0" aria-label="Normal" aria-selected="true" href="javascript:void(0)">Normal</a></li> <li data-v-190c1992="" class="wk-icon-filled-check"><a data-v-190c1992="" tabindex="0" aria-label="Large" href="javascript:void(0)" aria-selected="false">Large</a></li></ul></nav></div></li></ul></div> <!----> <!----> <section data-v-8430aa75="" id="topicOutline" class="topicOutline" style="display: none; top: 0px !important; padding-top: 0px;"><!----> <div data-v-8430aa75="" id="outlineContent" class="ds1-mb-8"></div></section> <article data-v-8430aa75="" id="topicArticle" class="topicArticle"><div id="printHeader" class="simpleHeader clearfix">
  <div id="headerSimpleLeft" class="float">
        <img class="wk-wheel" src="/images/logos/utd-wheel-icon.svg" width="40" height="auto">
        <img src="/images/logos/utd-logo.svg" width="130" height="auto" alt="UpToDate">
      <div id="printHeaderText">Official reprint from UpToDate<sup>®</sup>
      <br>
      <a href="https://www.uptodate.com">www.uptodate.com</a>
              © 2025 UpToDate, Inc. and/or its affiliates. All Rights Reserved.
    </div>
  </div>
</div>
<div id="topicContent" class="utdArticleSection utdStyle xhash_topicContent_scrollTarget"><div id="topicTitle">跨性别女性的评估和管理</div><div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/contributors" class="contributor contributor_credentials" target="_blank" rel="noopener noreferrer">Vin Tangpricha, MD, PhD</a></dd><dd><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/contributors" class="contributor contributor_credentials" target="_blank" rel="noopener noreferrer">Joshua D Safer, MD, FACP, FACE</a></dd><dt><span> </span>Section Editors:</dt><dd><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/contributors" class="contributor contributor_credentials" target="_blank" rel="noopener noreferrer">Peter J Snyder, MD</a></dd><dd><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/contributors" class="contributor contributor_credentials" target="_blank" rel="noopener noreferrer">Alvin M Matsumoto, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/contributors" class="contributor contributor_credentials" target="_blank" rel="noopener noreferrer">Kathryn A Martin, MD</a></dd></dl><dl id="chineseContributors"><dt><span> </span>翻译:</dt><dd><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/contributors" class="contributor contributor_credentials" target="_blank" rel="noopener noreferrer">杨力, 副主任医师</a></dd></dl></div><div class="authorsElementsRight"><div id="reviewProcess"><span>所有专题都会依据新发表的证据和<a href="/home/editorial-policy" target="_blank" class="policy policy_editorialpolicy">同行评议过程</a>而更新。</span></div><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">文献评审有效期至：</span>&nbsp;2025-01.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">专题最后更新日期：</span>&nbsp;2023-10-12.</bdi></div></div></div></div><div id="translatedTopicOutOfDate"><div class="translatedOutOfDate1"><bdi>There is a newer version of this topic available in <span><a href="/contents/transgender-women-evaluation-and-management?source=Out+of+date+-+zh-Hans" class="lang">English</a></span>.</bdi></div><div class="translatedOutOfDate2">该专题有一个更新版本<span><a href="/contents/transgender-women-evaluation-and-management?source=Out+of+date+-+zh-Hans" class="lang">英文版本</a></span>。</div></div><p id="disclaimerLink">请阅读本页末的<a href="#disclaimerContent" data-see-link-view-event="">免责声明</a>。</p><div id="topicText"><p class="headingAnchor css_h1" id="H1"><span class="h1">引言</span><span class="headingEndMark">&nbsp;—&nbsp;</span></p><p class="css_h1">“跨性别”和“性别不一致”都是指个体的性别认同与其生殖生物学其他方面(通常是出生时的外生殖器)不一致。医护人员应熟悉常用术语 (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F86993&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef86993 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 1</a>)。想要接受性别确认治疗的患者可选择激素治疗和手术，以及脱毛或言语治疗等其他方法[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/1,2" class="abstract_t">1,2</a>]。 </p><p class="css_h1">本专题将使用广义上的跨性别者，包括性别认同与出生时记录的性别(通常基于出生时所见外生殖器)不一致的所有患者。下文将讨论跨性别女性的评估和管理。跨性别男性的评估和管理、跨性别成人的初级保健、儿童和青少年的性别多元化以及性别确认手术详见其他专题。(参见 <a href="/contents/zh-Hans/transgender-men-evaluation-and-management?topicRef=7456&amp;source=see_link" class="medical medical_review">“跨性别男性的评估与管理”</a>和 <a href="/contents/primary-care-of-transgender-individuals?topicRef=7456&amp;source=see_link" class="medical medical_review">“Primary care of transgender individuals”</a>和 <a href="/contents/zh-Hans/gender-development-and-clinical-presentation-of-gender-diversity-in-children-and-adolescents?topicRef=7456&amp;source=see_link" class="medical medical_review">“儿童和青少年性别发展及性别多元化的临床表现”</a>和 <a href="/contents/zh-Hans/management-of-transgender-and-gender-diverse-children-and-adolescents?topicRef=7456&amp;source=see_link" class="medical medical_review">“跨性别或性别多元化儿童和青少年的管理”</a>和 <a href="/contents/gender-affirming-surgery-feminizing-procedures?topicRef=7456&amp;source=see_link" class="medical medical_review">“Gender-affirming surgery: Feminizing procedures”</a>)</p><p class="headingAnchor css_h1" id="H1084578518"><span class="h1">流行病学</span></p><p class="bulletIndent1 css_h1"><span class="glyph">●</span><strong>发生率</strong>–现有数据表明0.6%的成人为跨性别者[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/3-5" class="abstract_t">3-5</a>]。跨性别的发生率取决于定义。例如，一些研究仅纳入接受了激素治疗、性别确认手术或证实跨性别(有对应诊断代码)的患者，结果显示跨性别发生率为7-9例/100,000人[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/6" class="abstract_t">6</a>]。但在纳入自述跨性别者的研究中，跨性别的发生率约为871例/100,000人[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/6" class="abstract_t">6</a>]。 </p><p></p><p class="bulletIndent1 css_h1">调查研究表明，自述跨性别者在成人中占0.5%，在青少年中占2.7%[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/7" class="abstract_t">7</a>]。据一项研究估计，全球约有2500万跨性别者[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/8" class="abstract_t">8</a>]。寻求性别确认治疗的人数一直在增加，这可能是由于跨性别者感到更加安全而敢于表达自己。然而，寻求治疗的人数仍远低于根据匿名自我调查预期的人数。 </p><p></p><p class="bulletIndent1 css_h1"><span class="glyph">●</span><strong>生物学基础证据</strong>–虽然具体机制仍不明确，但有一些证据表明性别认同存在生物学基础[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/9" class="abstract_t">9</a>]。性别认同具有生物学基础的证据主要包括：</p><p></p><p class="bulletIndent2 css_h1"><span class="glyph">•</span>双性人(又称性别发育差异)的性别认同数据。</p><p></p><p class="bulletIndent2 css_h1"><span class="glyph">•</span>双胞胎数据显示，同卵双胞胎跨性别的一致性比异卵双胞胎高[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/10" class="abstract_t">10</a>]。</p><p></p><p class="bulletIndent2 css_h1"><span class="glyph">•</span>与性别认同相关的神经解剖学差异[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/11" class="abstract_t">11</a>]。</p><p></p><p class="bulletIndent2 css_h1"><span class="glyph">•</span>产前雄激素暴露的潜在影响[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/12" class="abstract_t">12</a>]。</p><p></p><p class="bulletIndent1 css_h1">大多数此类研究的样本量较小，因此需要进一步研究以确定性别认同的具体生物学机制[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/9" class="abstract_t">9</a>]。</p><p></p><p class="headingAnchor css_h1" id="H2277441687"><span class="h1">初始表现</span><span class="headingEndMark">&nbsp;—&nbsp;</span></p><p class="css_h1">跨性别成人通常自述早在青春期之前就一直受到性别不一致的困扰。 </p><p class="bulletIndent1 css_h1"><span class="glyph">●</span><strong>年龄</strong>–大多数跨性别者在成年期或青春发育后期就诊。随着公众媒体曝光率提高、社会接受度上升和就医机会增加，跨性别者的就诊年龄相比过去更小[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/13" class="abstract_t">13</a>]。</p><p></p><p class="bulletIndent1 css_h1"><span class="glyph">●</span><strong>初始医护人员</strong>–虽然一些跨性别者会寻求心理医生诊断，但目前很多跨性别者会先向初级保健医生寻求初步指导。另一些跨性别者会直接看内分泌科医生，以接受激素治疗。</p><p></p><p class="bulletIndent1 css_h1"><span class="glyph">●</span><strong>同时存在心理健康问题</strong>–一些跨性别者同时存在心境障碍[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/14" class="abstract_t">14</a>]，这可能通过性别确认激素治疗改善[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/15-17" class="abstract_t">15-17</a>]。</p><p></p><p class="headingAnchor css_h1" id="H695967249"><span class="h1">诊断</span></p><p class="css_h1">应让有资质的医护人员诊断性别不一致，其应熟悉诊断标准[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/18,19" class="abstract_t">18,19</a>]，并有必要的经验来评估是否存在心理健康问题，这些问题可能混淆诊断且需要在考虑激素治疗之前予以处理 (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F86993&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef86993 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 1</a>)。</p><p class="headingAnchor css_h2" id="H1539322596"><span class="h2">性别不一致</span><span class="headingEndMark">&nbsp;—&nbsp;</span>性别不一致的当前诊断标准是长期存在性别认同与出生时记录的性别(通常基于出生时所见外生殖器)不一致。</p><p class="css_h2">必须先诊断性别不一致才能考虑性别确认激素治疗和手术治疗[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/18" class="abstract_t">18</a>]。诊断应排除同时存在的心理健康问题。(参见下文<a href="#H3202886987" class="local" data-see-link-view-event="">‘治疗前评估’</a>)</p><p class="css_h2">此外，考虑激素治疗前必须明确诊断可能需要治疗的躯体疾病[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/18,19" class="abstract_t">18,19</a>]。(参见下文<a href="#H3202886987" class="local" data-see-link-view-event="">‘治疗前评估’</a>)</p><p class="css_h2">目前，大多数跨性别认同病例仍在成年期确诊，但越来越多的跨性别者于儿童期和青少年期就诊和治疗。儿童性别多元化的临床表现详见其他专题。(参见 <a href="/contents/zh-Hans/gender-development-and-clinical-presentation-of-gender-diversity-in-children-and-adolescents?sectionName=%E4%B8%B4%E5%BA%8A%E8%A1%A8%E7%8E%B0&amp;topicRef=7456&amp;anchor=H2166514667&amp;source=see_link#H2166514667" class="medical medical_review">“儿童和青少年性别发展及性别多元化的临床表现”，关于‘临床表现’一节</a>)</p><p class="headingAnchor css_h2" id="H1666820704"><span class="h2">性别烦躁</span><span class="headingEndMark">&nbsp;—&nbsp;</span>患者还可能确诊性别烦躁，即性别认同与出生时记录的性别不一致而引起不适。在WHO ICD-10中，性别烦躁目前是跨性别的诊断代码，但它属于心理健康代码。需注意，ICD-11将删除“性别烦躁”，代码将变为“性别不一致”。跨性别者的心理健康代码与其他个体相同。 </p><p class="css_h2">性别烦躁通常由心理医生确诊，但其他经验丰富、训练有素的医生也可做出诊断。心理医生的诊断依据通常是第五版《精神障碍诊断与统计手册》(DSM-5)[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/20" class="abstract_t">20</a>]。DSM-5中性别烦躁诊断标准的核心是，性别认同与出生时的外生殖器不一致引起长期不适，并影响社会、学校及其他方面的表现[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/20" class="abstract_t">20</a>]。</p><p class="headingAnchor css_h1" id="H7"><span class="h1">激素治疗</span></p><p class="headingAnchor css_h2" id="H3202886987"><span class="h2">治疗前评估</span></p><p class="headingAnchor css_h3" id="H3507458527"><span class="h3">诊疗指南/标准</span><span class="headingEndMark">&nbsp;—&nbsp;</span>几家大型专业医学机构发布了相关指南，包括世界跨性别者健康专业协会[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/7" class="abstract_t">7</a>]、美国内分泌学会[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/18" class="abstract_t">18</a>] (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F86993&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef86993 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 1</a>)和美国妇产科医师学会[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/21" class="abstract_t">21</a>]，以帮助医护人员评估和治疗跨性别者。</p><p class="headingAnchor css_h3" id="H3286212879"><span class="h3">开始激素治疗的标准</span><span class="headingEndMark">&nbsp;—&nbsp;</span>开始激素治疗的标准包括[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/7" class="abstract_t">7</a>]：</p><p class="bulletIndent1 css_h3"><span class="glyph">●</span>长期存在明确的性别烦躁或性别不一致</p><p class="bulletIndent1 css_h3"><span class="glyph">●</span>有能力给出知情同意</p><p class="bulletIndent1 css_h3"><span class="glyph">●</span>应充分解决心理健康问题，以推进治疗 </p><p></p><p class="headingAnchor css_h3" id="H2558040780"><span class="h3">治疗基础躯体疾病</span><span class="headingEndMark">&nbsp;—&nbsp;</span>除了这些既定标准，医生还应处理可能受到激素治疗影响的躯体疾病或危险因素，最重要的是心血管危险因素。在开始激素治疗前，还需评估和治疗雌激素的一些相对禁忌证，包括乳腺癌、静脉血栓栓塞(venous thromboembolism, VTE)、心血管疾病(cardiovascular disease, CVD)、脑血管疾病以及严重肝功能障碍的病史。如果患者存在高催乳素血症，应评估后再使用雌二醇。(参见下文<a href="#H768005246" class="local" data-see-link-view-event="">‘不良事件’</a>)</p><p class="headingAnchor css_h3" id="H101306913"><span class="h3">患者咨询</span><span class="headingEndMark">&nbsp;—&nbsp;</span>医生在开始激素治疗前应讨论一系列问题，包括患者的治疗目标、预期、治疗的利弊、对未来生育力的潜在影响。</p><p class="bulletIndent1 css_h3"><span class="glyph">●</span><strong>目标</strong>–性别确认激素治疗的目标通常为诱导身体变化，以符合性别认同[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/22" class="abstract_t">22</a>]。治疗目标是使激素水平维持在女性生理范围内。单用雌激素会抑制促性腺激素分泌，从而抑制雄激素生成，但加用第二种抑制雄激素分泌或作用的药物可能减少雌激素的用量，从而可能降低VTE的风险。(参见下文<a href="#H768005246" class="local" data-see-link-view-event="">‘不良事件’</a>)</p><p></p><p class="bulletIndent1 css_h3"><span class="glyph">●</span><strong>医疗团队</strong>–跨性别者最好应找擅长跨性别者初级保健、性别确认激素治疗以及心理健康支持的医生治疗。</p><p></p><p class="bulletIndent1 css_h3"><span class="glyph">●</span><strong>预期</strong>–许多跨性别女性会优先考虑使胡须停止生长、诱导乳房形成、改变声音以及使脂肪/肌肉分布更加女性化。为此需要将雄激素的生物效应降低至女性水平。与已接受治疗的跨性别者交流可帮助患者调整对跨性别治疗的预期，了解治疗期间可能出现的个体和社会问题。家人/照料者和朋友的支持通常很重要。</p><p></p><p class="bulletIndent1 css_h3">激素治疗带来的身体变化速度有所不同。一些变化在几个月内出现(皮肤变软)，而另一些(乳房发育)则需数年 (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F54189&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef54189 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 2</a>)。(参见下文<a href="#H3650613053" class="local" data-see-link-view-event="">‘女性化作用’</a>)</p><p></p><p class="bulletIndent1 css_h3"><span class="glyph">●</span><strong>治疗的利弊</strong>–患者应充分了解激素或手术治疗的利弊[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/23,24" class="abstract_t">23,24</a>]。(参见下文<a href="#H384457094" class="local" data-see-link-view-event="">‘临床结局’</a>)</p><p></p><p class="bulletIndent1 css_h3"><span class="glyph">●</span><strong>未来的生育力</strong>–性别确认治疗可能使跨性别女性失去生育力。因此，开始任何治疗前，应建议患者首先考虑生育问题[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/19" class="abstract_t">19</a>](参见下文<a href="#H1860228424" class="local" data-see-link-view-event="">‘生育问题’</a>)。然而，性别确认激素治疗并不能可靠地抑制精子发生(即不育或低生育力并非一定存在，也并非永久性)。因此，对于与顺性别女性进行阴道性交的跨性别女性，应讨论避孕方案[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/25-29" class="abstract_t">25-29</a>]。</p><p></p><p class="headingAnchor css_h2" id="H331025"><span class="h2">抑制雄激素</span><span class="headingEndMark">&nbsp;—&nbsp;</span>降低血清雄激素浓度和拮抗雄激素受体的方法包括： </p><p class="css_h2"><a href="/contents/zh-Hans/92479?topicRef=7456&amp;source=see_link" data-topicid="92479" class="drug drug_dxy">螺内酯</a>(美国)、促性腺激素释放激素(gonadotropin-releasing hormone, GnRH)激动剂和<a href="/contents/zh-Hans/125846?topicRef=7456&amp;source=see_link" data-topicid="125846" class="drug drug_dxy">醋酸环丙孕酮</a>(cyproterone acetate, CPA；欧洲)效果良好，因此用作一线治疗。睾丸切除术等性别确认生殖器手术后，可停止抗雄激素治疗[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/30,31" class="abstract_t">30,31</a>]。 </p><p class="css_h2"><a href="/contents/zh-Hans/92479?topicRef=7456&amp;source=see_link" data-topicid="92479" class="drug drug_dxy">螺内酯</a>和CPA也可治疗多毛症。(参见 <a href="/contents/zh-Hans/management-of-hirsutism-in-premenopausal-females?sectionName=%E6%8A%97%E9%9B%84%E6%BF%80%E7%B4%A0%E8%8D%AF%E7%89%A9&amp;topicRef=7456&amp;anchor=H2273583496&amp;source=see_link#H2273583496" class="medical medical_review">“绝经前女性多毛症的治疗”，关于‘抗雄激素药物’一节</a>)</p><p class="bulletIndent1 css_h2"><span class="glyph">●</span><strong></strong><a href="/contents/zh-Hans/92479?topicRef=7456&amp;source=see_link" data-topicid="92479" class="drug drug_dxy">螺内酯</a>–螺内酯是一种盐皮质激素受体拮抗剂，是美国跨性别女性中应用最广泛的药物。它既是雄激素受体的竞争性抑制剂，又是睾酮生物合成的抑制剂(通过抑制17-羟化酶和17,20-裂解酶)[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/32-36" class="abstract_t">32-36</a>]。 </p><p></p><p class="bulletIndent1 css_h2"><a href="/contents/zh-Hans/92479?topicRef=7456&amp;source=see_link" data-topicid="92479" class="drug drug_dxy">螺内酯</a>的推荐剂量为100-300mg/d (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F69460&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef69460 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 3</a>)[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/37" class="abstract_t">37</a>]。 </p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span><strong>GnRH激动剂</strong>–GnRH激动剂能够抑制促性腺激素和睾酮分泌，因此是理想疗法[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/18,38" class="abstract_t">18,38</a>]。由于其价格较高，过去用作二线治疗。但目前一些国家(包括英国)对跨性别女性常规使用GnRH激动剂，而美国的保险覆盖问题导致其较少使用。此类药物的给药方案见表 (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F69460&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef69460 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 3</a>)。</p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span><strong>CPA</strong>–CPA既是孕激素(可抑制促性腺激素)，又是雄激素受体拮抗剂，该药在除美国以外的大多数国家有售。由于CPA可能引起血脂状况恶化、催乳素小幅升高以及罕见的脑膜瘤，现已不太常用[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/39,40" class="abstract_t">39,40</a>]。</p><p></p><p class="bulletIndent1 css_h2">如果使用CPA，剂量应控制在≤10mg/d，以免发生不良反应[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/18" class="abstract_t">18</a>]。此外，10mg CPA联用雌二醇抑制血清睾酮＜2nmol/L(＜58ng/dL)的效果与更高剂量的CPA相同[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/41" class="abstract_t">41</a>]。 <strong> </strong></p><p></p><p class="headingAnchor css_h2" id="H10"><span class="h2">雌激素治疗</span><span class="headingEndMark">&nbsp;—&nbsp;</span>常用方法为通过雌激素治疗抑制内源性雄激素分泌，以雌激素取代。可选择的雌激素很多 (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F69460&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef69460 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 3</a>)，但首选的雌激素是17-β-雌二醇。 </p><p class="css_h2">在绝经后女性中，经皮雌激素的VTE和脑卒中风险低于口服雌激素。但口服雌二醇比经皮雌二醇便宜很多，而且跨性别女性发生VTE的基线风险较低，因此往往使用口服制剂。 </p><p class="css_h2">我们建议使用17-β-雌二醇而不是<a href="/contents/zh-Hans/100806?topicRef=7456&amp;source=see_link" data-topicid="100806" class="drug drug_dxy">结合雌激素</a>，以便监测血清雌二醇水平。 </p><p class="css_h2">睾丸健全的跨性别女性可能需要较大剂量的雌激素，才能将睾酮控制在女性生理范围内，甚至还需联用GnRH激动剂或抗雄激素药物。</p><p class="css_h2">常用的雌二醇方案包括 (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F69460&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef69460 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 3</a>)：</p><p class="bulletIndent1 css_h2"><span class="glyph">●</span>透皮制剂，0.025-0.2mg/24小时。根据产品的不同，每周更换1次或2次贴剂。</p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span>口服制剂，2-6mg/d[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/18,42" class="abstract_t">18,42</a>]。 </p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span>在欧洲，也可使用口服17-β<a href="/contents/zh-Hans/124111?topicRef=7456&amp;source=see_link" data-topicid="124111" class="drug drug_dxy">戊酸雌二醇</a>，剂量为2-4mg/d。</p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span>有时使用胃肠外雌激素(<a href="/contents/zh-Hans/124111?topicRef=7456&amp;source=see_link" data-topicid="124111" class="drug drug_dxy">戊酸雌二醇</a>或环戊丙酸雌二醇) (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F69460&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef69460 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 3</a>)。</p><p></p><p class="css_h2">口服炔雌醇是有效的雌激素，用于大多数雌-孕激素复方口服避孕药，但我们建议跨性别者不要使用。曾有跨性别女性使用50-100μg/d的炔雌醇，但静脉血栓形成风险增加，心血管死亡风险增加，尤其是40岁以上患者[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/32,43-46" class="abstract_t">32,43-46</a>]。(参见下文<a href="#H768005246" class="local" data-see-link-view-event="">‘不良事件’</a>)</p><p class="css_h2">应坚持雌激素治疗，以避免性激素缺乏症状，防止骨丢失和骨质疏松[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/47-49" class="abstract_t">47-49</a>]。雌激素的合适剂量见上文及附表 (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F69460&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef69460 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 3</a>)。</p><p class="css_h2">在开始激素治疗前，还需要评估和治疗雌激素的一些相对禁忌证，包括乳腺癌、VTE、CVD、脑血管疾病以及严重肝功能障碍病史。如患者存在高催乳素血症，应治疗后再使用雌二醇。(参见下文<a href="#H768005246" class="local" data-see-link-view-event="">‘不良事件’</a>)</p><p class="headingAnchor css_h2" id="H2353216727"><span class="h2">不常规使用的药物</span></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span><strong>孕激素</strong>–虽然有时使用醋酸甲羟孕酮(medroxyprogesterone acetate, MPA)等孕激素来抑制促性腺激素，进而抑制睾酮分泌，但我们不建议在跨性别女性的标准激素治疗中纳入孕激素。如果中老年女性在绝经后使用<a href="/contents/zh-Hans/100806?topicRef=7456&amp;source=see_link" data-topicid="100806" class="drug drug_dxy">结合雌激素</a>，则MPA会增加心血管和乳腺癌风险。(参见 <a href="/contents/zh-Hans/menopausal-hormone-therapy-benefits-and-risks?sectionName=%E5%A5%B3%E6%80%A7%E5%81%A5%E5%BA%B7%E8%A1%8C%E5%8A%A8&amp;topicRef=7456&amp;anchor=H168740206&amp;source=see_link#H168740206" class="medical medical_review">“绝经期激素治疗的利弊”，关于‘女性健康行动’一节</a>) </p><p></p><p class="bulletIndent1 css_h2">CPA在跨性别女性中的危害见上文。(参见上文<a href="#H331025" class="local" data-see-link-view-event="">‘抑制雄激素’</a>)</p><p></p><p class="bulletIndent1 css_h2">另一些孕激素与雌激素合用时会增加VTE风险[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/50" class="abstract_t">50</a>]。一篇关于跨性别女性使用孕激素的系统评价发现，孕激素几乎没有益处，还增加了危害，包括降低HDL-C水平和增加血栓形成风险[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/40" class="abstract_t">40</a>]。</p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span><strong></strong><a href="/contents/zh-Hans/92577?topicRef=7456&amp;source=see_link" data-topicid="92577" class="drug drug_dxy">非那雄胺</a>和<a href="/contents/zh-Hans/92573?topicRef=7456&amp;source=see_link" data-topicid="92573" class="drug drug_dxy">度他雄胺</a>–非那雄胺可抑制5-α还原酶2的活性，度他雄胺可抑制5-α还原酶1和2的活性，从而抑制睾酮转化为更强效的二氢睾酮。这些药物用于治疗良性前列腺增生、前列腺癌、男性/女性脱发，有时还用于治疗女性多毛症。尚无非那雄胺和度他雄胺用于跨性别者的数据，但若睾酮水平下降，没有底物可生成二氢睾酮，则这些药物几乎没有作用。(参见 <a href="/contents/zh-Hans/male-pattern-hair-loss-androgenetic-alopecia-in-males-management?sectionName=%E5%8F%A3%E6%9C%8D%E9%9D%9E%E9%82%A3%E9%9B%84%E8%83%BA&amp;topicRef=7456&amp;anchor=H13&amp;source=see_link#H13" class="medical medical_review">“男性型脱发(男性雄激素性脱发)的治疗”，关于‘口服非那雄胺’一节</a>和 <a href="/contents/zh-Hans/management-of-hirsutism-in-premenopausal-females?sectionName=%E6%8A%97%E9%9B%84%E6%BF%80%E7%B4%A0%E8%8D%AF%E7%89%A9&amp;topicRef=7456&amp;anchor=H2273583496&amp;source=see_link#H2273583496" class="medical medical_review">“绝经前女性多毛症的治疗”，关于‘抗雄激素药物’一节</a>)</p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span><strong></strong><a href="/contents/zh-Hans/92582?topicRef=7456&amp;source=see_link" data-topicid="92582" class="drug drug_dxy">氟他胺</a>和<a href="/contents/zh-Hans/93124?topicRef=7456&amp;source=see_link" data-topicid="93124" class="drug drug_dxy">尼鲁米特</a>–建议不要使用非甾体类抗雄激素药物，例如氟他胺和尼鲁米特。它们会增加促性腺激素的分泌，导致睾酮和雌二醇的分泌增加，但只有雌二醇增加有利。更重要的是，氟他胺有肝毒性。(参见 <a href="/contents/zh-Hans/management-of-hirsutism-in-premenopausal-females?sectionName=%E6%8A%97%E9%9B%84%E6%BF%80%E7%B4%A0%E8%8D%AF%E7%89%A9&amp;topicRef=7456&amp;anchor=H2273583496&amp;source=see_link#H2273583496" class="medical medical_review">“绝经前女性多毛症的治疗”，关于‘抗雄激素药物’一节</a>)</p><p></p><p class="headingAnchor css_h2" id="H3444626406"><span class="h2">监测</span><span class="headingEndMark">&nbsp;—&nbsp;</span>跨性别女性接受激素治疗时，每次剂量调整都应行临床监测，在第1年通常每3个月监测1次。当情况稳定时(通常是在1年后)，应每年监测1-2次 (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F67967&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef67967 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 4</a>)。除了临床上评估患者是否对方案满意，还需监测以下项目：</p><p class="bulletIndent1 css_h2"><span class="glyph">●</span>若患者希望采用常规方法，则监测血清总睾酮水平是否处于女性生理范围。最好使用质谱法测定睾酮水平[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/51" class="abstract_t">51</a>]。</p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span>对于使用<a href="/contents/zh-Hans/92479?topicRef=7456&amp;source=see_link" data-topicid="92479" class="drug drug_dxy">螺内酯</a>的患者，在治疗第1个月后和调整剂量后测定血清钾浓度。在使用螺内酯且肾功能正常的跨性别女性中，高钾血症的发生率较低，因此不必更频繁地测定血清钾浓度 (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F67967&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef67967 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 4</a>)[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/52,53" class="abstract_t">52,53</a>]。 </p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span>应监测雌二醇浓度，以免超过生理水平，例如维持在200pg/mL(734pmol/L)以下 (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F67967&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef67967 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 4</a>)。 </p><p></p><p class="bulletIndent1 css_h2">一些指南建议监测血清催乳素水平，因为接受性别确认激素治疗的跨性别女性偶可出现催乳素升高[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/18" class="abstract_t">18</a>]。然而，只有含CPA的方案与催乳素水平升高相关[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/54" class="abstract_t">54</a>]。仅有几项研究评估了跨性别女性使用雌激素+<a href="/contents/zh-Hans/92479?topicRef=7456&amp;source=see_link" data-topicid="92479" class="drug drug_dxy">螺内酯</a>，也未发现对催乳素水平有类似的影响[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/55,56" class="abstract_t">55,56</a>]。对于顺性别女性，雌激素不会增加血清催乳素水平，也不会导致催乳素瘤。建议在开始性别确认激素治疗之前测定基线催乳素水平，以便治疗既存的高催乳素血症。 </p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span><strong>癌症筛查</strong></p><p></p><p class="bulletIndent2 css_h2"><span class="glyph">•</span>目前没有针对跨性别者的相关数据，故应遵循女性标准乳房筛查指南。(参见 <a href="/contents/primary-care-of-transgender-individuals?sectionName=Breast+cancer&amp;topicRef=7456&amp;anchor=H417309145&amp;source=see_link#H417309145" class="medical medical_review">“Primary care of transgender individuals”, section on ‘Breast cancer’</a>)</p><p></p><p class="bulletIndent2 css_h2"><span class="glyph">•</span>存在前列腺组织的患者都需筛查前列腺癌。目前没有针对跨性别者的相关数据，故应遵循顺性别男性标准前列腺筛查指南[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/18" class="abstract_t">18</a>]，即便前列腺癌在行生殖器手术(包括性腺切除术)的跨性别女性中较罕见。(参见 <a href="/contents/primary-care-of-transgender-individuals?sectionName=Prostate+cancer&amp;topicRef=7456&amp;anchor=H417309171&amp;source=see_link#H417309171" class="medical medical_review">“Primary care of transgender individuals”, section on ‘Prostate cancer’</a>) </p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span><strong>骨健康</strong>–对于风险较低的跨性别女性，美国内分泌学会建议从60岁开始筛查骨质疏松，对于不依从激素治疗的患者应更早开始[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/18" class="abstract_t">18</a>]。(参见 <a href="/contents/primary-care-of-transgender-individuals?topicRef=7456&amp;source=see_link" class="medical medical_review">“Primary care of transgender individuals”</a>)</p><p></p><p class="headingAnchor css_h1" id="H384457094"><span class="h1">临床结局</span></p><p class="headingAnchor css_h2" id="H3650613053"><span class="h2">女性化作用</span><span class="headingEndMark">&nbsp;—&nbsp;</span>虽然治疗目标是减少激素诱导形成的男性第二性征(若GnRH激动剂未能延迟青春期)，但不可能完全消除。对于跨性别女性，雄激素对骨骼的影响无法逆转，如身高、手脚、颌部和盆骨的大小和形状以及声音(有喉结)。</p><p class="css_h2">但确实会有很多变化 (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F54189&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef54189 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 2</a>)。前3-6个月的变化包括性欲可能减退，以及胡须和体毛的生长变慢。乳房组织也会开始发育，皮肤油脂分泌减少，而且脂肪早期重新分布[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/18" class="abstract_t">18</a>]。血细胞比容/血红蛋白水平会随着睾酮水平降低而下降[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/57" class="abstract_t">57</a>]。</p><p class="css_h2">主要临床结局包括 (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F54189&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef54189 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 2</a>)：</p><p class="bulletIndent1 css_h2"><span class="glyph">●</span><strong>胡须</strong>–联合激素治疗很难抑制成年男性的胡须生长，尤其是欧裔男性，通常需要其他方法，例如激光脱毛或电解脱毛。12.9%的依氟鸟氨酸乳膏可减缓面部毛发生长，但由于成本问题及需要一日2次持续涂抹才能维持效果，其使用受到一定限制。(参见 <a href="/contents/zh-Hans/management-of-hirsutism-in-premenopausal-females?sectionName=%E7%9B%B4%E6%8E%A5%E8%84%B1%E6%AF%9B%E6%96%B9%E6%B3%95%E7%9A%84%E4%BD%9C%E7%94%A8&amp;topicRef=7456&amp;anchor=H4194241682&amp;source=see_link#H4194241682" class="medical medical_review">“绝经前女性多毛症的治疗”，关于‘直接脱毛方法的作用’一节</a>)</p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span><strong>乳房发育</strong>–开始使用雌激素后，乳房几乎立刻就开始发育，通常在2年时发育到最大[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/32,58-60" class="abstract_t">32,58-60</a>]。乳房发育期间可能出现乳头触痛和不适。雄激素会抑制乳房发育，因此在睾酮水平降至女性生理范围时雌激素最有效。</p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span><strong>皮肤</strong>–睾酮水平降低会减少皮脂腺分泌，可能导致皮肤干燥或指(趾)甲变脆[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/61" class="abstract_t">61</a>]。</p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span><strong>身体组成</strong>–睾酮水平降低后，皮下脂肪增加，去脂体重降低[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/62" class="abstract_t">62</a>]，总体重通常随着BMI的增加而增加[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/63" class="abstract_t">63</a>]。</p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span><strong></strong>睾丸–如果没有手术切除，睾丸会在多年内逐渐萎缩。如果没有促性腺激素刺激，睾丸会逐渐萎缩，偶尔还可能进入腹股沟管，引起不适。</p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span><strong>前列腺</strong>–前列腺也会在多年内逐渐萎缩。</p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span><strong>声音</strong>–雌激素和抗雄激素治疗不能改变声音特征，因此跨性别女性可选择咨询专业的语音矫正中心，接受言语治疗。治疗重点通常为声调和共鸣，因为人们主要就是通过这两种声音特征感知说话人的性别[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/64" class="abstract_t">64</a>]。言语治疗可使声音更女性化[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/65" class="abstract_t">65</a>]。有研究报道，喉部手术可改变声音的声调，但会使音域变窄。</p><p></p><p class="bulletIndent1 css_h2"><span class="glyph">●</span><strong>性功能</strong>–女性化激素治疗会使跨性别女性性欲减退、勃起功能减弱、射精减少[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/66" class="abstract_t">66</a>]。部分跨性别女性会选择减少激素剂量来平衡女性化程度与性功能，而有的患者则表示不需要调整剂量。接受生殖器手术后，跨性别女性的性功能(性欲、性唤起、性交痛和性高潮)各不相同，取决于术前性功能、手术类型和激素状态[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/67" class="abstract_t">67</a>]。</p><p></p><p class="headingAnchor css_h2" id="H1537695997"><span class="h2">社会心理结局</span><span class="headingEndMark">&nbsp;—&nbsp;</span>一篇meta分析纳入28项研究、共1833例跨性别者，包括1093例跨性别女性和801例跨性别男性，性别确认治疗(包括激素治疗)显著改善了生存质量和社会心理结局[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/15" class="abstract_t">15</a>]。汇总分析的证据表明，性别烦躁症状、心理功能、性功能和整体生存质量都有改善。一篇纳入20项研究的meta分析表明，生存质量得到改善，抑郁和焦虑减轻[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/68" class="abstract_t">68</a>]。 </p><p class="headingAnchor css_h2" id="H1670899541"><span class="h2">骨健康</span><span class="headingEndMark">&nbsp;—&nbsp;</span>国际临床骨密度测量学会推荐采用基于校正后女性参考数据库的T评分，来诊断50岁以上跨性别女性的骨质疏松[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/69" class="abstract_t">69</a>]。年龄较小者可用Z评分，选用与其性别认同相匹配的参考数据库。(参见 <a href="/contents/primary-care-of-transgender-individuals?topicRef=7456&amp;source=see_link" class="medical medical_review">“Primary care of transgender individuals”</a>)</p><p class="headingAnchor css_h2" id="H768005246"><span class="h2">不良事件</span></p><p class="headingAnchor css_h3" id="H3242655107"><span class="h3">心血管疾病</span><span class="headingEndMark">&nbsp;—&nbsp;</span>早期研究在接受性别确认激素治疗的跨性别女性中发现心血管事件风险增加，其部分原因可能是使用强效口服雌激素炔雌醇[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/46,70,71" class="abstract_t">46,70,71</a>]。 </p><p class="css_h3">观察性研究提示，跨性别女性使用雌激素可能增加CVD风险[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/72-76" class="abstract_t">72-76</a>]，这可能是由于其对CVD危险因素的有害影响[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/77,78" class="abstract_t">77,78</a>]。据报道，持续的性少数群体压力可能增加跨性别女性的心血管风险[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/79" class="abstract_t">79</a>]。(参见 <a href="/contents/primary-care-of-transgender-individuals?sectionName=Cardiovascular+disease&amp;topicRef=7456&amp;anchor=H417308963&amp;source=see_link#H417308963" class="medical medical_review">“Primary care of transgender individuals”, section on ‘Cardiovascular disease’</a>和 <a href="/contents/zh-Hans/overview-of-established-risk-factors-for-cardiovascular-disease?topicRef=7456&amp;source=see_link" class="medical medical_review">“确定的心血管疾病危险因素概述”</a>)</p><p class="css_h3">一些流行病学研究显示，与顺性别女性相比，跨性别女性发生心肌梗死和缺血性脑卒中的风险更高。然而，一篇meta分析纳入29项研究、共3200余例接受激素治疗的跨性别女性，结果发现血清甘油三酯水平增加(口服雌激素)，但极少出现心肌梗死或脑卒中[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/75" class="abstract_t">75</a>]。859例患者中有8例(3%)出现脑卒中，1073例患者中有14例(1%)出现心肌梗死。其中一些事件发生于最初给予大剂量口服炔雌醇(100μg/d)的医疗中心[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/43" class="abstract_t">43</a>]。</p><p class="css_h3">在获得更多数据前，应排查激素治疗的跨性别者的CVD危险因素[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/37,74" class="abstract_t">37,74</a>]。(参见 <a href="/contents/primary-care-of-transgender-individuals?sectionName=Cardiovascular+disease&amp;topicRef=7456&amp;anchor=H417308963&amp;source=see_link#H417308963" class="medical medical_review">“Primary care of transgender individuals”, section on ‘Cardiovascular disease’</a>和 <a href="/contents/zh-Hans/overview-of-established-risk-factors-for-cardiovascular-disease?topicRef=7456&amp;source=see_link" class="medical medical_review">“确定的心血管疾病危险因素概述”</a>)</p><p class="headingAnchor css_h3" id="H2032297574"><span class="h3">静脉血栓栓塞症</span></p><p class="bulletIndent1 css_h3"><span class="glyph">●</span>研究表明，使用性别确认激素治疗的跨性别者，尤其是使用炔雌醇者，发生VTE的风险会增加[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/80" class="abstract_t">80</a>]。在使用非炔雌醇雌激素制剂的跨性别女性队列中，VTE风险并未增加[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/46" class="abstract_t">46</a>]。基于这些结果，当前指南推荐不要使用炔雌醇[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/18" class="abstract_t">18</a>]。</p><p></p><p class="bulletIndent1 css_h3"><span class="glyph">●</span>上述一篇纳入29项研究的meta分析显示[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/75" class="abstract_t">75</a>]，1767例跨性别女性中有56例(3%)出现VTE。</p><p></p><p class="bulletIndent1 css_h3"><span class="glyph">●</span>另一篇meta分析纳入18项研究，共11,000余例接受性别确认激素治疗的跨性别女性，发现VTE的总发生率为2%[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/81" class="abstract_t">81</a>]。年龄在37.5岁以下者未发生VTE事件，而年龄在37.5以上者的VTE发生率为3%。 </p><p></p><p class="bulletIndent1 css_h3"><span class="glyph">●</span>一项基于电子病历的队列研究纳入2842例跨性别女性，以及与之匹配的顺性别男性和顺性别女性各约48,000例，结果发现跨性别女性的VTE发生率(5.5例/1000人年)高于两个对照组[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/82" class="abstract_t">82</a>]。大多数跨性别女性都在接受口服雌二醇，平均最大日剂量为4mg(1-10mg)，VTE患者的剂量没有差别。 </p><p></p><p class="bulletIndent1 css_h3">随访时间越长，这种差异越显著，与顺性别男性相比，2年和8年时的绝对危险度差异分别为4.1/1000人和16.7/1000人，与顺性别女性相比分别为3.4/1000人和13.7/1000人。这种现象与接受激素治疗的绝经后女性不同，后者的VTE风险在治疗第一年最高，随后降低。由此说明，对跨性别女性进行长期监测很重要。(参见 <a href="/contents/zh-Hans/menopausal-hormone-therapy-and-cardiovascular-risk?sectionName=%E9%9D%99%E8%84%89%E8%A1%80%E6%A0%93%E6%A0%93%E5%A1%9E&amp;topicRef=7456&amp;anchor=H18&amp;source=see_link#H18" class="medical medical_review">“绝经期激素治疗和心血管风险”，关于‘静脉血栓栓塞’一节</a>)</p><p></p><p class="bulletIndent1 css_h3"><span class="glyph">●</span>通常在围术期会停止性别确认雌激素治疗，以尽量降低VTE风险。然而，一项来自单中心的回顾性研究报道，围术期停用雌激素患者的VTE发生率与继续使用雌激素的患者相近[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/83" class="abstract_t">83</a>]。相关内容详见其他专题。(参见 <a href="/contents/gender-affirming-surgery-feminizing-procedures?sectionName=Perioperative+management+of+systemic+estrogen+therapy&amp;topicRef=7456&amp;anchor=H1851606949&amp;source=see_link#H1851606949" class="medical medical_review">“Gender-affirming surgery: Feminizing procedures”, section on ‘Perioperative management of systemic estrogen therapy’</a>) </p><p></p><p class="bulletIndent1 css_h3"><span class="glyph">●</span>跨性别人群与一般人群的易栓症发生率相同。因此，不建议在治疗前常规筛查易栓症。 </p><p></p><p class="headingAnchor css_h3" id="H2728322199"><span class="h3">其他</span></p><p class="bulletIndent1 css_h3"><span class="glyph">●</span><strong></strong>甘油三酯–据报道，在雌激素治疗期间，甘油三酯升高的风险略有增加。但若甘油三酯水平非常高[&gt;2000mg/dL(22.59mmol/L)]，患者有发生急性胰腺炎的风险。一篇纳入16项研究的meta分析发现，跨性别激素治疗会略微升高血清甘油三酯水平[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/75" class="abstract_t">75</a>]。有已知家族性高甘油三酯血症的个体不应使用口服雌激素[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/84,85" class="abstract_t">84,85</a>]。</p><p></p><p class="bulletIndent1 css_h3"><span class="glyph">●</span><strong>死亡率</strong>–曾有早期研究报道跨性别女性死亡率升高，但原因可能是治疗失败引起的并发症，而非治疗本身。例如，一项研究纳入966例跨性别女性的和365例跨性别男性，跨性别者的死亡率比一般人群高51%，主要死于药物滥用、HIV、CVD和自杀[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/46" class="abstract_t">46</a>]。口服炔雌醇(已不在跨性别女性中使用的雌激素)使心血管死亡风险增至3倍。</p><p></p><p class="bulletIndent1 css_h3">一项跨性别者研究通过10年随访发现，目前估计的死亡率为9.3%。死因与同一时期美国一般人群相似，但跨性别者的自杀率高于一般人群[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/86" class="abstract_t">86</a>]。一个队列的最新数据显示，与顺性别男性和女性的预期死亡率相比，跨性别女性的死亡率增加，但跨性别男性的死亡率未增加[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/87,88" class="abstract_t">87,88</a>]。与顺性别男性和女性相比，跨性别女性因CVD、感染、癌症和非自然原因(包括自杀)所致死亡率上升。 </p><p></p><p class="headingAnchor css_h1" id="H1860228424"><span class="h1">生育问题</span><span class="headingEndMark">&nbsp;—&nbsp;</span></p><p class="css_h1">对于打算接受性别确认激素治疗或手术治疗的跨性别者，应鼓励其考虑生育问题[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/89,90" class="abstract_t">89,90</a>]。跨性别女性可以冻存精子(最好在开始激素治疗之前)[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/91" class="abstract_t">91</a>]。不过，只有一部分患者利用了冻存精子技术。一份纳入99例跨性别女性的报告显示，有75例考虑冻存精子，但只有9例付诸实践[<a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/92,93" class="abstract_t">92,93</a>]。(参见 <a href="/contents/zh-Hans/effects-of-cytotoxic-agents-on-gonadal-function-in-adult-men?sectionName=%E7%B2%BE%E6%B6%B2%E5%86%BB%E5%AD%98&amp;topicRef=7456&amp;anchor=H34&amp;source=see_link#H34" class="medical medical_review">“细胞毒药物对成年男性性腺功能的影响”，关于‘精液冻存’一节</a>)</p><p class="headingAnchor css_h1" id="H3494664244"><span class="h1">性别确认手术</span><span class="headingEndMark">&nbsp;—&nbsp;</span></p><p class="css_h1">即便不做性别确认手术，跨性别者也能够且成功以符合自己性别认同的性别角色生活。手术治疗前所需采取的步骤见上文。这些患者的性别确认手术方法详见其他专题。(参见 <a href="/contents/gender-affirming-surgery-feminizing-procedures?topicRef=7456&amp;source=see_link" class="medical medical_review">“Gender-affirming surgery: Feminizing procedures”</a>)</p><p class="headingAnchor css_h1" id="H3654077874"><span class="h1">学会指南链接</span><span class="headingEndMark">&nbsp;—&nbsp;</span></p><p class="css_h1">部分国家及地区的学会指南和政府指南的链接参见其他专题。(参见 <a href="/contents/society-guideline-links-transgender-health?topicRef=7456&amp;source=see_link" class="medical medical_society_guidelines">“Society guideline links: Transgender health”</a>)</p><p class="headingAnchor css_h1" id="H28836485"><span class="h1">患者教育</span><span class="headingEndMark">&nbsp;—&nbsp;</span></p><p class="css_h1">UpToDate提供两种类型的患者教育资料：“基础篇”和“高级篇”。基础篇通俗易懂，相当于5-6年级阅读水平(美国)，可以解答关于某种疾病患者可能想了解的4-5个关键问题；基础篇更适合想了解疾病概况且喜欢阅读简短易读资料的患者。高级篇篇幅较长，内容更深入详尽；相当于10-12年级阅读水平(美国)，适合想深入了解并且能接受一些医学术语的患者。</p><p class="css_h1">以下是与此专题相关的患者教育资料。我们建议您以打印或电子邮件的方式给予患者。(您也可以通过检索“患者教育”和关键词找到更多相关专题内容。)</p><p class="bulletIndent1 css_h1"><span class="glyph">●</span>基础篇(参见 <a href="/contents/zh-Hans/being-transgender-the-basics?topicRef=7456&amp;source=see_link" class="medical medical_basics">“患者教育：跨性别者(基础篇)”</a>)</p><p></p><p class="headingAnchor css_h1" id="H331321"><span class="h1">总结与推荐</span></p><p class="bulletIndent1 css_h1"><span class="glyph">●</span><strong>定义–</strong>跨性别者泛指所有多元性别者，例如性别认同与出生时记录的性别不一致。这类个体觉得自己是跨性别男性、跨性别女性或非二元性别者(即同时具有两性特征) (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F86993&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef86993 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 1</a>)。(参见上文<a href="#H1" class="local" data-see-link-view-event="">‘引言’</a>)</p><p></p><p class="bulletIndent1 css_h1"><span class="glyph">●</span><strong>诊断–</strong>应由具备相关经验的医生证实跨性别者的性别不一致。必须确定性别不一致长期存在，且患者能够理解治疗的风险和益处。(参见上文<a href="#H2277441687" class="local" data-see-link-view-event="">‘初始表现’</a>)</p><p></p><p class="bulletIndent1 css_h1"><span class="glyph">●</span><strong>激素治疗</strong>–开始跨性别激素治疗或手术治疗之前，医生应告知患者激素治疗或手术治疗的利弊，包括对生育力的影响，以及切实的结局预期。(参见上文<a href="#H101306913" class="local" data-see-link-view-event="">‘患者咨询’</a>)</p><p></p><p class="bulletIndent1 css_h1">对于跨性别女性的雌激素治疗，建议采用经皮或口服17-β-雌二醇(<a href="/contents/grade/6?title=Grade 2C&amp;topicKey=ENDO/7456" class="grade">Grade 2C</a>)。建议不要使用炔雌醇，以免增加静脉血栓栓塞症(VTE)风险(参见上文<a href="#H10" class="local" data-see-link-view-event="">‘雌激素治疗’</a>)。此外，建议加用促性腺激素释放激素(GnRH)激动剂来抑制雄激素，以及<a href="/contents/zh-Hans/92479?topicRef=7456&amp;source=see_link" data-topicid="92479" class="drug drug_dxy">螺内酯</a>或小剂量<a href="/contents/zh-Hans/125846?topicRef=7456&amp;source=see_link" data-topicid="125846" class="drug drug_dxy">醋酸环丙孕酮</a>(CPA)来抑制雄激素作用 (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F69460&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef69460 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 3</a>)。</p><p></p><p class="bulletIndent1 css_h1">应监测接受激素治疗的跨性别女性，以免血清雌二醇超过生理水平，例如应维持其水平＜200pg/mL(734pmol/L)，并确认血清睾酮水平处于女性生理范围内 (<a href="/contents/zh-Hans/image?imageKey=ENDO%2F67967&amp;topicKey=ENDO%2F7456&amp;source=see_link" class="graphic graphic_table graphicRef67967 graphic-hover-tooltip-unique-wkutdComponentId_83" data-gfx-modal-btn="">表 4</a>)。调整<a href="/contents/zh-Hans/92479?topicRef=7456&amp;source=see_link" data-topicid="92479" class="drug drug_dxy">螺内酯</a>剂量时，应检测血清钾水平。(参见上文<a href="#H3444626406" class="local" data-see-link-view-event="">‘监测’</a>)</p><p></p><p class="bulletIndent1 css_h1"><span class="glyph">●</span><strong>不良反应</strong>–对于跨性别女性，雌激素治疗最重要的风险为VTE。(参见上文<a href="#H3242655107" class="local" data-see-link-view-event="">‘心血管疾病’</a>)</p><p></p><p class="bulletIndent1 css_h1"><span class="glyph">●</span><strong>筛查指南</strong>–我们同意美国内分泌学会的指南：无论跨性别者的性别认同如何，只要存在某种组织，就应按相关指南筛查。例如，存在前列腺的跨性别者应筛查前列腺癌。(参见上文<a href="#H3444626406" class="local" data-see-link-view-event="">‘监测’</a>)</p><p></p><p class="bulletIndent1 css_h1"><span class="glyph">●</span><strong>手术</strong>–性别确认手术详见其他专题。(参见 <a href="/contents/gender-affirming-surgery-feminizing-procedures?topicRef=7456&amp;source=see_link" class="medical medical_review">“Gender-affirming surgery: Feminizing procedures”</a>)</p><p></p><p class="headingAnchor css_h1" id="H15570543"><span class="h1">致谢</span><span class="headingEndMark">&nbsp;—&nbsp;</span></p><p class="css_h1">UpToDate的编辑人员感谢Louis JG Gooren, MD对本专题早期版本做出的贡献。</p></div><div id="references" class="headingAnchor"><h1>参考文献</h1><ol id="reference"><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/1" class="nounderline abstract_t">Coleman E, Bockting W, Botzer M, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgend 2012; 13:165.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/2" class="nounderline abstract_t">Safer JD, Tangpricha V. Care of the Transgender Patient. Ann Intern Med 2019; 171:ITC1.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/3" class="nounderline abstract_t">Conron KJ, Scott G, Stowell GS, Landers SJ. Transgender health in Massachusetts: results from a household probability sample of adults. Am J Public Health 2012; 102:118.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/4" class="nounderline abstract_t">Reisner SL, Conron KJ, Tardiff LA, et al. Monitoring the health of transgender and other gender minority populations: validity of natal sex and gender identity survey items in a U.S. national cohort of young adults. BMC Public Health 2014; 14:1224.</a></li><li class="breakAll">https://williamsinstitute.law.ucla.edu/wp-content/uploads/How-Many-Adults-Identify-as-Transgender-in-the-United-States.pdf (Accessed on May 23, 2018).</li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/6" class="nounderline abstract_t">Collin L, Reisner SL, Tangpricha V, Goodman M. Prevalence of Transgender Depends on the "Case" Definition: A&nbsp;Systematic Review. J Sex Med 2016; 13:613.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/7" class="nounderline abstract_t">Coleman E, Radix AE, Bouman WP, et al. Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgend Health 2022; 23:259.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/8" class="nounderline abstract_t">Winter S, Diamond M, Green J, et al. Transgender people: health at the margins of society. Lancet 2016; 388:390.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/9" class="nounderline abstract_t">Saraswat A, Weinand JD, Safer JD. Evidence supporting the biologic nature of gender identity. Endocr Pract 2015; 21:199.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/10" class="nounderline abstract_t">Heylens G, De Cuypere G, Zucker KJ, et al. Gender identity disorder in twins: a review of the case report literature. J Sex Med 2012; 9:751.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/11" class="nounderline abstract_t">Luders E, Sánchez FJ, Tosun D, et al. Increased Cortical Thickness in Male-to-Female Transsexualism. J Behav Brain Sci 2012; 2:357.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/12" class="nounderline abstract_t">Wilson JD. The role of androgens in male gender role behavior. Endocr Rev 1999; 20:726.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/13" class="nounderline abstract_t">Leinung MC, Urizar MF, Patel N, Sood SC. Endocrine treatment of transsexual persons: extensive personal experience. Endocr Pract 2013; 19:644.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/14" class="nounderline abstract_t">Terada S, Matsumoto Y, Sato T, et al. Factors predicting psychiatric co-morbidity in gender-dysphoric adults. Psychiatry Res 2012; 200:469.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/15" class="nounderline abstract_t">Murad MH, Elamin MB, Garcia MZ, et al. Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes. Clin Endocrinol (Oxf) 2010; 72:214.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/16" class="nounderline abstract_t">Smith YL, van Goozen SH, Cohen-Kettenis PT. Adolescents with gender identity disorder who were accepted or rejected for sex reassignment surgery: a prospective follow-up study. J Am Acad Child Adolesc Psychiatry 2001; 40:472.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/17" class="nounderline abstract_t">Colizzi M, Costa R, Todarello O. Transsexual patients' psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: results from a longitudinal study. Psychoneuroendocrinology 2014; 39:65.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/18" class="nounderline abstract_t">Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2017; 102:3869.</a></li><li class="breakAll">World Professional Association for Transgender Health. Standards of care for gender identity disorders. http://wpath.org/publications_standards.cfm (Accessed on September 13, 2011).</li><li class="breakAll">American Psychiatric Association. Gender dysphoria. In: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, American Psychiatric Association, Arlington, VA 2013. p.451.</li><li class="breakAll">http://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Health-Care-for-Underserved-Women/Health-Care-for-Transgender-Individuals (Accessed on August 03, 2016).</li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/22" class="nounderline abstract_t">Gooren L. Hormone treatment of the adult transsexual patient. Horm Res 2005; 64 Suppl 2:31.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/23" class="nounderline abstract_t">Gooren LJ. Clinical practice. Care of transsexual persons. N Engl J Med 2011; 364:1251.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/24" class="nounderline abstract_t">Weinand JD, Safer JD. Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals. J Clin Transl Endocrinol 2015; 2:55.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/25" class="nounderline abstract_t">Mancini I, Alvisi S, Gava G, et al. Contraception across transgender. Int J Impot Res 2020; 33:710.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/26" class="nounderline abstract_t">Schneider F, Kliesch S, Schlatt S, Neuhaus N. Andrology of male-to-female transsexuals: influence of cross-sex hormone therapy on testicular function. Andrology 2017; 5:873.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/27" class="nounderline abstract_t">Jindarak S, Nilprapha K, Atikankul T, et al. Spermatogenesis Abnormalities following Hormonal Therapy in Transwomen. Biomed Res Int 2018; 2018:7919481.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/28" class="nounderline abstract_t">Kent MA, Winoker JS, Grotas AB. Effects of Feminizing Hormones on Sperm Production and Malignant Changes: Microscopic Examination of Post Orchiectomy Specimens in Transwomen. Urology 2018; 121:93.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/29" class="nounderline abstract_t">de Nie I, van Mello NM, Vlahakis E, et al. Successful restoration of spermatogenesis following gender-affirming hormone therapy in transgender women. Cell Rep Med 2023; 4:100858.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/30" class="nounderline abstract_t">Zitzmann M, Erren M, Kamischke A, et al. Endogenous progesterone and the exogenous progestin norethisterone enanthate are associated with a proinflammatory profile in healthy men. J Clin Endocrinol Metab 2005; 90:6603.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/31" class="nounderline abstract_t">Angus L, Leemaqz S, Ooi O, et al. Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy. Endocr Connect 2019; 8:935.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/32" class="nounderline abstract_t">Moore E, Wisniewski A, Dobs A. Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab 2003; 88:3467.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/33" class="nounderline abstract_t">Tangpricha V, Ducharme SH, Barber TW, Chipkin SR. Endocrinologic treatment of gender identity disorders. Endocr Pract 2003; 9:12.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/34" class="nounderline abstract_t">Menard RH, Stripp B, Gillette JR. Spironolactone and testicular cytochrome P-450: decreased testosterone formation in several species and changes in hepatic drug metabolism. Endocrinology 1974; 94:1628.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/35" class="nounderline abstract_t">Spironolactone and endocrine dysfunction. Ann Intern Med 1976; 85:630.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/36" class="nounderline abstract_t">Stripp B, Taylor AA, Bartter FC, et al. Effect of spironolactone on sex hormones in man. J Clin Endocrinol Metab 1975; 41:777.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/37" class="nounderline abstract_t">Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, et al. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2009; 94:3132.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/38" class="nounderline abstract_t">Dittrich R, Binder H, Cupisti S, et al. Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist. Exp Clin Endocrinol Diabetes 2005; 113:586.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/39" class="nounderline abstract_t">Nota NM, Wiepjes CM, de Blok CJM, et al. The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment. Brain 2018; 141:2047.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/40" class="nounderline abstract_t">Patel KT, Adeel S, Rodrigues Miragaya J, Tangpricha V. Progestogen Use in Gender-Affirming Hormone Therapy: A Systematic Review. Endocr Pract 2022; 28:1244.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/41" class="nounderline abstract_t">Kuijpers SME, Wiepjes CM, Conemans EB, et al. Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study. J Clin Endocrinol Metab 2021; 106:e3936.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/42" class="nounderline abstract_t">Chantrapanichkul P, Stevenson MO, Suppakitjanusant P, et al. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY. Endocr Pract 2021; 27:27.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/43" class="nounderline abstract_t">van Kesteren PJ, Asscheman H, Megens JA, Gooren LJ. Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf) 1997; 47:337.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/44" class="nounderline abstract_t">Toorians AW, Thomassen MC, Zweegman S, et al. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab 2003; 88:5723.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/45" class="nounderline abstract_t">Asscheman H, T'Sjoen G, Lemaire A, et al. Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review. Andrologia 2014; 46:791.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/46" class="nounderline abstract_t">Asscheman H, Giltay EJ, Megens JA, et al. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol 2011; 164:635.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/47" class="nounderline abstract_t">van Kesteren P, Lips P, Gooren LJ, et al. Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones. Clin Endocrinol (Oxf) 1998; 48:347.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/48" class="nounderline abstract_t">Mueller A, Dittrich R, Binder H, et al. High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone. Eur J Endocrinol 2005; 153:107.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/49" class="nounderline abstract_t">Ruetsche AG, Kneubuehl R, Birkhaeuser MH, Lippuner K. Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study. Osteoporos Int 2005; 16:791.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/50" class="nounderline abstract_t">Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ 2019; 364:k4810.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/51" class="nounderline abstract_t">La'ulu SL, Kalp KJ, Straseski JA. How low can you go? Analytical performance of five automated testosterone immunoassays. Clin Biochem 2018; 58:64.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/52" class="nounderline abstract_t">Gupta P, Suppakitjanusant P, Stevenson M, et al. Potassium Concentrations in Transgender Women Using Spironolactone: A Retrospective Chart Review. Endocr Pract 2022; 28:1113.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/53" class="nounderline abstract_t">Plovanich M, Weng QY, Mostaghimi A. Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne. JAMA Dermatol 2015; 151:941.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/54" class="nounderline abstract_t">Nota NM, Dekker MJ, Klaver M, et al. Prolactin levels during short- and long-term cross-sex hormone treatment: an observational study in transgender persons. Andrologia 2016.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/55" class="nounderline abstract_t">Bisson JR, Chan KJ, Safer JD. PROLACTIN LEVELS DO NOT RISE AMONG TRANSGENDER WOMEN TREATED WITH ESTRADIOL AND SPIRONOLACTONE. Endocr Pract 2018; 24:646.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/56" class="nounderline abstract_t">Sofer Y, Yaish I, Yaron M, et al. Differential Endocrine and Metabolic Effects of Testosterone Suppressive Agents in Transgender Women. Endocr Pract 2020; 26:883.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/57" class="nounderline abstract_t">Harper J, O'Donnell E, Sorouri Khorashad B, et al. How does hormone transition in transgender women change body composition, muscle strength and haemoglobin? Systematic review with a focus on the implications for sport participation. Br J Sports Med 2021; 55:865.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/58" class="nounderline abstract_t">Levy A, Crown A, Reid R. Endocrine intervention for transsexuals. Clin Endocrinol (Oxf) 2003; 59:409.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/59" class="nounderline abstract_t">Gooren LJ, Giltay EJ. Men and women, so different, so similar: observations from cross-sex hormone treatment of transsexual subjects. Andrologia 2014; 46:570.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/60" class="nounderline abstract_t">Gooren LJ, Giltay EJ, Bunck MC. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab 2008; 93:19.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/61" class="nounderline abstract_t">Giltay EJ, Gooren LJ. Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females. J Clin Endocrinol Metab 2000; 85:2913.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/62" class="nounderline abstract_t">Lapauw B, Taes Y, Simoens S, et al. Body composition, volumetric and areal bone parameters in male-to-female transsexual persons. Bone 2008; 43:1016.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/63" class="nounderline abstract_t">Suppakitjanusant P, Ji Y, Stevenson MO, et al. Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study. J Clin Transl Endocrinol 2020; 21:100230.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/64" class="nounderline abstract_t">Hancock AB, Garabedian LM. Transgender voice and communication treatment: a retrospective chart review of 25 cases. Int J Lang Commun Disord 2013; 48:54.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/65" class="nounderline abstract_t">de Bruin MD, Coerts MJ, Greven AJ. Speech therapy in the management of male-to-female transsexuals. Folia Phoniatr Logop 2000; 52:220.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/66" class="nounderline abstract_t">Feldman J, Safer J. Hormone therapy in adults: suggested revisions to the sixth version of the standards of care. Int J Transgend 2009; 11:146.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/67" class="nounderline abstract_t">Klein C, Gorzalka BB. Sexual functioning in transsexuals following hormone therapy and genital surgery: a review. J Sex Med 2009; 6:2922.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/68" class="nounderline abstract_t">Baker KE, Wilson LM, Sharma R, et al. Hormone Therapy, Mental Health, and Quality of Life Among Transgender People: A Systematic Review. J Endocr Soc 2021; 5:bvab011.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/69" class="nounderline abstract_t">Rosen HN, Hamnvik OR, Jaisamrarn U, et al. Bone Densitometry in Transgender and Gender Non-Conforming (TGNC) Individuals: 2019 ISCD Official Position. J Clin Densitom 2019; 22:544.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/70" class="nounderline abstract_t">Wierckx K, Elaut E, Declercq E, et al. Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study. Eur J Endocrinol 2013; 169:471.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/71" class="nounderline abstract_t">Wierckx K, Mueller S, Weyers S, et al. Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med 2012; 9:2641.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/72" class="nounderline abstract_t">Gooren LJ, Wierckx K, Giltay EJ. Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern. Eur J Endocrinol 2014; 170:809.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/73" class="nounderline abstract_t">Connelly PJ, Marie Freel E, Perry C, et al. Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults. Hypertension 2019; 74:1266.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/74" class="nounderline abstract_t">Streed CG Jr, Harfouch O, Marvel F, et al. Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy: A Narrative Review. Ann Intern Med 2017; 167:256.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/75" class="nounderline abstract_t">Maraka S, Singh Ospina N, Rodriguez-Gutierrez R, et al. Sex Steroids and Cardiovascular Outcomes in Transgender Individuals: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab 2017; 102:3914.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/76" class="nounderline abstract_t">Nota NM, Wiepjes CM, de Blok CJM, et al. Occurrence of Acute Cardiovascular Events in Transgender Individuals Receiving Hormone Therapy. Circulation 2019; 139:1461.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/77" class="nounderline abstract_t">Gooren LJ, Giltay EJ, Bunck MC. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab 2008; 93:19.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/78" class="nounderline abstract_t">Elamin MB, Garcia MZ, Murad MH, et al. Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses. Clin Endocrinol (Oxf) 2010; 72:1.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/79" class="nounderline abstract_t">Streed CG Jr, Beach LB, Caceres BA, et al. Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association. Circulation 2021; 144:e136.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/80" class="nounderline abstract_t">Goldstein Z, Khan M, Reisman T, Safer JD. Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy. J Blood Med 2019; 10:209.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/81" class="nounderline abstract_t">Totaro M, Palazzi S, Castellini C, et al. Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study. Front Endocrinol (Lausanne) 2021; 12:741866.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/82" class="nounderline abstract_t">Getahun D, Nash R, Flanders WD, et al. Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study. Ann Intern Med 2018; 169:205.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/83" class="nounderline abstract_t">Kozato A, Fox GWC, Yong PC, et al. No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender-Affirming Surgery. J Clin Endocrinol Metab 2021; 106:e1586.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/84" class="nounderline abstract_t">Goldenberg NM, Wang P, Glueck CJ. An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia. Clin Chim Acta 2003; 332:11.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/85" class="nounderline abstract_t">Goldberg RB, Chait A. A Comprehensive Update on the Chylomicronemia Syndrome. Front Endocrinol (Lausanne) 2020; 11:593931.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/86" class="nounderline abstract_t">Blosnich JR, Brown GR, Wojcio S, et al. Mortality Among Veterans with Transgender-Related Diagnoses in the Veterans Health Administration, FY2000-2009. LGBT Health 2014; 1:269.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/87" class="nounderline abstract_t">de Blok CJ, Wiepjes CM, van Velzen DM, et al. Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria. Lancet Diabetes Endocrinol 2021; 9:663.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/88" class="nounderline abstract_t">Tangpricha V. Health disparities in transgender people. Lancet Diabetes Endocrinol 2021; 9:641.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/89" class="nounderline abstract_t">TʼSjoen G, Van Caenegem E, Wierckx K. Transgenderism and reproduction. Curr Opin Endocrinol Diabetes Obes 2013; 20:575.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/90" class="nounderline abstract_t">Wallace SA, Blough KL, Kondapalli LA. Fertility preservation in the transgender patient: expanding oncofertility care beyond cancer. Gynecol Endocrinol 2014; 30:868.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/91" class="nounderline abstract_t">Sermondade N, Benaloun E, Berthaut I, et al. Reproductive functions and fertility preservation in transgender women: a French case series. Reprod Biomed Online 2021; 43:339.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/92" class="nounderline abstract_t">Mayhew AC, Gomez-Lobo V. Fertility Options for the Transgender and Gender Nonbinary Patient. J Clin Endocrinol Metab 2020; 105:3335.</a></li><li><a href="/contents/zh-Hans/transgender-women-evaluation-and-management/abstract/93" class="nounderline abstract_t">Auer MK, Fuss J, Nieder TO, et al. Desire to Have Children Among Transgender People in Germany: A Cross-Sectional Multi-Center Study. J Sex Med 2018; 15:757.</a></li></ol></div><div id="disclaimer" class="xhash_disclaimerContent_scrollTarget">免责声明：这类广义信息是对诊断、治疗和/或药物信息的有限总结。这类信息不一定全面，应将其用作帮助用户理解和/或评估潜在诊断和治疗选择的工具。其中并不包含关于可能应用于某个特定患者的条件、治疗、药物、副作用或风险的所有信息。其目的不是作为医疗建议，也不作为医疗保健提供者根据其检查或对患者具体而独特的情况所做出的医疗建议、诊断或治疗的替代。患者必须与医疗保健提供者交谈，以获得关于他们的健康、医疗问题和治疗选择的完整信息，包括任何有关使用药物的风险或好处。此类信息不将任何治疗或药物作为治疗某个特定患者的安全、有效或“批准”的推荐。UpToDate, Inc. 及其附属公司不承担与这类信息或其使用相关的任何担保或责任。
这类信息的使用受使用条款的约束，欲查看使用条款，请访问此网站： <a href="https://www.wolterskluwer.com/en/know/clinical-effectiveness-terms" target="_blank" rel="noopener noreferrer" track="enabled">https://www.wolterskluwer.com/en/know/clinical-effectiveness-terms</a>. 2025© UpToDate, Inc. 及其附属公司和/或许可方。保留所有权利。</div><div id="topicVersionRevision">专题 7456 版本 23.0.zh-Hans.1.0</div></div><div id="printGraphics" class="print-section-hidden"><h1>图表</h1><div class="graphic" style="page-break-after: always;" data-gfx-modal-btn=""><div class="figure"><div class="ttl">Terms used to describe various aspects of gender and sexuality<sup>*</sup></div><div class="cntnt"><table cellspacing="0"><colgroup width="30%"></colgroup><colgroup width="70%"></colgroup> <tbody> <tr class="highlight_gray_text"> <td class="subtitle2_left_white">Sex designated at birth/sex recorded on original birth certificate/sex assigned at birth</td> <td>Sex (typically male or female) assigned/designated according to external genitalia.</td> </tr> <tr> <td class="subtitle2_left_white">Gender identity</td> <td>Innate sense of feeling male, female, some combination of both, or neither.</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Nonbinary gender identity</li> </ul> </td> <td> <p>Gender identity that is neither exclusively male nor exclusively female; may be some combination of the 2, something else entirely, or fluid.</p> <p class="extra_spacing_top">Other terms that may be used for nonbinary gender identity include genderqueer, gender-creative, gender-independent, bigender, noncisgender, agender, and gender blender, among others.</p> </td> </tr> <tr class="highlight_gray_text"> <td class="subtitle2_left_white">Gender expression</td> <td>How gender is presented (eg, feminine, masculine, androgynous); gender expression does not necessarily correlate with birth-designated sex or gender identity.</td> </tr> <tr> <td class="subtitle2_left_white">Gender diversity</td> <td>Variation in gender identity, expression, or gender role behavior (eg, in choices of clothing, hairstyle, toys, playmates); "gender diversity" acknowledges a spectrum of gender identities.</td> </tr> <tr class="highlight_gray_text"> <td class="subtitle2_left_white">Transgender, trans, gender incongruence</td> <td>Umbrella terms used to describe individuals whose gender identity is not strictly aligned with other biology; transgender and trans are used as adjectives ("transgender people"), not nouns ("transgenders").</td> </tr> <tr class="highlight_gray_text"> <td> <ul class="decimal_heading"> <li>Transgender man/transmasculine individual</li> </ul> </td> <td>Person with male gender identity who was recorded/designated female sex at birth.</td> </tr> <tr class="highlight_gray_text"> <td> <ul class="decimal_heading"> <li>Transgender woman/transfeminine individual</li> </ul> </td> <td>Person with female gender identity who was recorded/designated male sex at birth.</td> </tr> <tr> <td class="subtitle2_left_white">Gender dysphoria</td> <td>Distress or discomfort that may occur when gender identity and other biology is not strictly aligned. This term will be discarded in ICD-11 in favor of a sexual health designation that does not require dysphoria for the label.</td> </tr> <tr class="highlight_gray_text"> <td class="subtitle2_left_white">Transsexual</td> <td>Older, clinical term that has fallen out of favor; historically, it was used to refer to transgender people who sought gender-affirming medical or surgical interventions.</td> </tr> <tr> <td class="subtitle2_left_white">Sexual orientation</td> <td> <p>An individual's pattern of physical and emotional arousal and the gender(s) of persons to whom an individual is physically, romantically, or sexually attracted (gay/lesbian, straight, bisexual).</p> <p class="extra_spacing_top">The sexual orientation of transgender people is based upon their gender identity (eg, a transmasculine individual who is attracted to other men might identify as a gay man; a transfeminine individual who is attracted to other women might identify as a lesbian).</p> </td> </tr> <tr class="highlight_gray_text"> <td class="subtitle2_left_white">Sexual behaviors</td> <td>Specific behaviors involving sexual activities independent of traditional labeling.</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>ICD-11: International Classification of Diseases, 11th Revision.</p>
<p class="extra_spacing_top">* These are cultural and descriptive terms, not diagnostic terms.</p></div><div class="graphic_reference">References:
<ol>
    <li>World Professional Association for Transgender Health (WPATH). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Available at: <a href="https://www.tandfonline.com/doi/pdf/10.1080/26895269.2022.2100644" target="_blank">https://www.tandfonline.com/doi/pdf/10.1080/26895269.2022.2100644</a> (Accessed on October 11, 2022).</li>
    <li>Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab 2017.</li>
    <li>Rafferty J, Committee on Psychosocial Aspects of Child and Family Health, Committee on Adolescence, Section on Lesbian, Gay, Bisexual, and Transgender Health and Wellness. Ensuring comprehensive care and support for transgender and gender-diverse children and adolescents. Pediatrics 2018; 142:e20182162.</li>
</ol></div><div id="graphicVersion">Graphic 86993 Version 15.0</div></div></div><div class="graphic" style="page-break-after: always;" data-gfx-modal-btn=""><div class="figure"><div class="ttl">Gender-affirming hormone treatment with feminizing effects</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr> <td class="subtitle1">Effect</td> <td class="subtitle1">Onset</td> <td class="subtitle1">Maximum</td> </tr> <tr> <td>Redistribution of body fat</td> <td>3 to 6 months</td> <td>2 to 3 years</td> </tr> <tr> <td>Decrease in muscle mass and strength</td> <td>3 to 6 months</td> <td>1 to 2 years</td> </tr> <tr> <td>Softening of skin/decreased oiliness</td> <td>3 to 6 months</td> <td>Unknown</td> </tr> <tr> <td>Decreased sexual desire</td> <td>1 to 3 months</td> <td>3 to 6 months</td> </tr> <tr> <td>Decreased spontaneous erections</td> <td>1 to 3 months</td> <td>3 to 6 months</td> </tr> <tr> <td>Male sexual dysfunction</td> <td>Variable</td> <td>Variable</td> </tr> <tr> <td>Breast growth</td> <td>3 to 6 months</td> <td>2 to 3 years</td> </tr> <tr> <td>Decreased testicular volume</td> <td>3 to 6 months</td> <td>2 to 3 years</td> </tr> <tr> <td>Decreased sperm production</td> <td>Unknown</td> <td>&gt;3 years</td> </tr> <tr> <td>Decreased terminal hair growth</td> <td>6 to 12 months</td> <td>&gt;3 years*</td> </tr> <tr> <td>Scalp hair</td> <td>Variable</td> <td>—<sup>¶</sup></td> </tr> <tr> <td>Voice changes</td> <td>None</td> <td>—<sup>Δ</sup></td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>* Complete removal of male sexual hair requires electrolysis or laser treatment or both.</p>
    
    <p>¶ Familial scalp hair loss may occur if estrogens are stopped.</p>
    
    Δ Treatment by speech pathologists for voice training is most effective.</div><div class="graphic_reference">Reproduced from: Hembree W, Cohen-Kettenis P, Gooren L. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2017; 102(11):3869-3903. By permission of Oxford University Press on behalf of the Endocrine Society. Copyright © 2017 Oxford University Press. Available at: <a href="https://www.endocrine.org/guidelines-and-clinical-practice/clinical-practice-guidelines/gender-dysphoria-gender-incongruence" target="_blank">https://www.endocrine.org/guidelines-and-clinical-practice/clinical-practice-guidelines/gender-dysphoria-gender-incongruence</a>.</div><div id="graphicVersion">Graphic 54189 Version 18.0</div></div></div><div class="graphic" style="page-break-after: always;" data-gfx-modal-btn=""><div class="figure"><div class="ttl">Hormone regimens for adult transgender persons</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr> <td class="subtitle1">&nbsp;</td> <td class="subtitle1">Dose range</td> <td class="subtitle1">Comment</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Transfeminine regimens<sup>*</sup></td> </tr> <tr> <td class="subtitle3_left" colspan="3"><strong>Estrogens</strong><sup>¶ </sup></td> </tr> <tr> <td class="indent2">Oral: estradiol (17-beta-estradiol valerate)</td> <td>2 to 6 mg/day</td> <td>Although some providers give higher doses of oral estradiol (greater than 6 mg/day), we suggest that only doses less than or equal to 6 mg/day be used.</td> </tr> <tr> <td class="indent2">Transdermal: estradiol patch</td> <td>0.025 to 0.2 mg per 24 hours, changed once or twice weekly, depending on specific preparation type</td> <td>Lower risk of thromboembolism compared with oral estrogen preparations.</td> </tr> <tr> <td class="indent2">Transdermal: estradiol gel</td> <td>0.25 to 1.25 mg applied once a day</td> <td>Lower risk of thromboembolism compared with oral estrogen preparations.</td> </tr> <tr> <td class="indent2" colspan="3">Parenteral</td> </tr> <tr> <td class="indent3">Estradiol valerate</td> <td>5 to 20 mg IM every two weeks</td> <td rowspan="2">Prolonged time to onset of effect and steady state, greater risk of accumulation and overdose.</td> </tr> <tr> <td class="indent3">Estradiol cypionate</td> <td>2 to 10 mg IM every week</td> </tr> <tr> <td class="subtitle3_left" colspan="3"><strong>Antiandrogens<sup>*</sup></strong></td> </tr> <tr> <td class="indent2">Spironolactone</td> <td>100 to 300 mg/day oral</td> <td>Monitor blood pressure and electrolytes.</td> </tr> <tr> <td class="indent2">Cyproterone acetate</td> <td>10 mg/day oral</td> <td>10 mg daily for a maximal duration of 2 years is recommended.</td> </tr> <tr> <td class="subtitle3_left" colspan="3"><strong>GnRH agonists</strong></td> </tr> <tr> <td class="indent2">Leuprolide</td> <td> <p>3.75 to 7.5 mg IM depot monthly</p> <p><strong>or</strong></p> 11.25 mg IM depot every 3 months</td> <td>Inhibits gonadotropin secretion.</td> </tr> <tr> <td class="indent2">Goserelin</td> <td>3.6 mg SQ implant monthly</td> <td>Expensive.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Transmasculine regimens</td> </tr> <tr> <td class="subtitle3_left" colspan="3"><strong>Testosterone</strong><sup>Δ</sup></td> </tr> <tr> <td class="indent2" colspan="3">Parenteral</td> </tr> <tr> <td class="indent3">Testosterone enanthate or cypionate</td> <td> <p>50 to 100 mg IM or SQ every week</p> <p><strong>or</strong></p> 100 to 200 mg IM every two weeks</td> <td>Weekly injections produce less peak-trough variation in effect (eg, mood); injection site reaction may occur.</td> </tr> <tr> <td class="indent3">Testosterone undecanoate<sup>◊</sup></td> <td>1000 mg IM every 10 to 12 weeks</td> <td>Produces stable physiologic testosterone levels over 10 to 13 weeks.</td> </tr> <tr> <td class="indent2" colspan="3">Transdermal</td> </tr> <tr> <td class="indent3">Testosterone gel 1% and 1.6%</td> <td>5 to 10 grams of gel per day (equivalent to 50 to 100 mg/day testosterone)</td> <td>Less variation in serum testosterone levels than injectable preparations; gel formulations can result in interpersonal transfer if contact occurs before fully dried (rare).</td> </tr> <tr> <td class="indent3">Testosterone patch</td> <td>2.5 to 7.5 mg/day transdermal</td> <td>Transdermal patch may produce lower serum testosterone levels and more skin irritation compared with gels.</td> </tr> </tbody></table></div><div class="graphic_lgnd">Suggestions shown in table are based upon case descriptions and experience. Regimen and dose must be carefully individualized based upon patient age, goals of therapy, whether pre- or postgonadectomy, and comorbid medical conditions and risks. Refer to UpToDate topics on transgender men and transgender females.</div><div class="graphic_footnotes"><p>GnRH: gonadotropin-releasing hormone; 
        IM: intramuscular; 
        SQ: subcutaneous.</p>
    
    <p>* Dose of estrogen should be adjusted according to serum 17-beta-estradiol levels (ie, 100 to 200 pg/mL) and effect. Lower doses of estradiol are generally sufficient for feminization goals when combined with an antiandrogen, GnRH agonist, or after gonadectomy. Antiandrogen therapy is discontinued after gonadectomy.</p>
    
    <p>¶  Synthetic estrogens (eg, ethinyl estradiol) are not recommended, due to elevated risk of thromboembolic disease, cardiovascular mortality, and inability to regulate dose by measurement of serum levels.</p>
    
    <p>Δ Doses of testosterone should be adjusted according to serum testosterone levels (ie, normal male range 320 to 1000 ng/dL) and effect. Time to onset of effect of parenteral preparations may be less than with transdermal preparations. Supplemental agents such as depot medroxyprogesterone 150 mg every 3 months or oral medroxyprogesterone 5 to 10 mg/day or oral lynestrenol 5 to 10 mg/day (not available in the United States) have been used as an add-on option when starting testosterone therapy to induce cessation of menses.</p>
    
    ◊ 1000 mg initially, followed by an injection at 6 weeks, then at 12-week intervals.</div><div class="graphic_reference">Adapted from: Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2017; 102:3869.</div><div id="graphicVersion">Graphic 69460 Version 10.0</div></div></div><div class="graphic" style="page-break-after: always;" data-gfx-modal-btn=""><div class="figure"><div class="ttl">Monitoring of transgender persons on gender-affirming hormone therapy: Transgender females</div><div class="cntnt"><table cellspacing="0"><tbody> <tr> <td> <ol class="numbers_to_nine"> <li>Evaluate patient every three months in the first year and then one to two times per year to monitor for appropriate signs of feminization and for development of adverse reactions. </li> </ol> </td> </tr> <tr> <td> <ol class="numbers_to_nine" start="2"> <li>Measure serum testosterone and estradiol every three months. </li> </ol> </td> </tr> <tr> <td> <ol class="numbers_to_nine"> <ol class="numbers_to_nine" style="list-style-type: lower-alpha;"> <li>Serum testosterone levels should be &lt;50 ng/dL. </li> </ol> </ol> </td> </tr> <tr> <td> <ol class="numbers_to_nine"> <ol class="numbers_to_nine" style="list-style-type: lower-alpha;" start="2"> <li>Serum estradiol should not exceed the peak physiologic range: 100 to 200 pg/mL. </li> </ol> </ol> </td> </tr> <tr> <td> <ol class="numbers_to_nine" start="3"> <li>For individuals on spironolactone, serum electrolytes (particularly potassium) should be monitored every three months in the first year and annually thereafter. </li> </ol> </td> </tr> <tr> <td> <ol class="numbers_to_nine" start="4"> <li>Routine cancer screening is recommended, as in nontransgender individuals (all tissues present). </li> </ol> </td> </tr> <tr> <td> <ol class="numbers_to_nine" start="5"> <li>Consider BMD testing at baseline<sup>[1]</sup>. In individuals at low risk, screening for osteoporosis should be conducted at age 60 years or in those who are not compliant with hormone therapy. </li> </ol> </td> </tr> </tbody></table></div><div class="graphic_lgnd">This table presents strong recommendations and does not include lower-level recommendations.</div><div class="graphic_footnotes">BMD: bone mineral density.</div><div class="graphic_reference">Reference:
	<ol>
		<li>Giltay EJ, Hoogeveen EK, Elbers JM, et al. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. J Clin Endocrinol Metab 1998; 83:550.</li>
	</ol>
	Reproduced from: Hembree W, Cohen-Kettenis P, Gooren L. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2017; 102(11):3869-3903. By permission of Oxford University Press on behalf of the Endocrine Society. Copyright © 2017. <a href="http://www.endocrine.org/guidelines-and-clinical-practice/clinical-practice-guidelines/gender-dysphoria-gender-incongruence" target="_blank">www.endocrine.org/guidelines-and-clinical-practice/clinical-practice-guidelines/gender-dysphoria-gender-incongruence</a>.</div><div id="graphicVersion">Graphic 67967 Version 18.0</div></div></div></div><div id="printDisclosures"><h1>Contributor Disclosures</h1><strong>Vin Tangpricha, MD, PhD</strong>Grant/Research/Clinical Trial Support: Cystic Fibrosis Foundation [Vitamin D, endocrinology and cystic fibrosis]; NIH [Vitamin D, transgender medicine].
Other Financial Interest: Dynamed – EBSCO [Reviewer]; Endocrine Practice – Elsevier [Editor-in-Chief].
All of the relevant financial relationships listed have been mitigated.<strong>Joshua D Safer, MD, FACP, FACE</strong>No relevant financial relationship(s) with ineligible companies to disclose.<strong>Peter J Snyder, MD</strong>Grant/Research/Clinical Trial Support: AbbVie [Hypogonadism]; Crinetics [Acromegaly, congenital adrenal hyperplasia]; Novartis [Cushing's]; Recordati [Cushing's].
Consultant/Advisory Boards: AbbVie [Hypogonadism]; Novartis [Cushing's]; Teva Pharmaceuticals [Cushing's disease].
All of the relevant financial relationships listed have been mitigated.<strong>Alvin M Matsumoto, MD</strong>Consultant/Advisory Boards: Partnership for Clean Competition [Anabolic steroid doping and testing]; Tolmar Pharma [Testosterone]; US Anti-Doping Agency [Board of Directors, performance enhancing drug doping and testing].
All of the relevant financial relationships listed have been mitigated.<strong>Kathryn A Martin, MD</strong>No relevant financial relationship(s) with ineligible companies to disclose.<p class="contributorDisclosureInfo">编辑组会认真审核作者的声明。之间的利益冲突将会通过编辑组对文章以及参考文献的多级审评来解决。 所有的作者都必须提供与文章相关的文献，文章以及文献须严格依循UpToDate 的相关的标准。</p><p class="contributorDisclosurePolicy"><a href="/home/conflict-interest-policy" target="_blank">利益矛盾的解决方案</a></p></div></article> <div data-v-e53a75f3="" data-v-8430aa75="" id="printControls" class="utd-print zh-Hans"><div data-v-e53a75f3="" class="print-controls-title"><h5 data-v-e53a75f3="">Print Options</h5></div> <div data-v-e53a75f3="" class="language-select"><div data-v-b9fc59f7="" data-v-e53a75f3="" class="wk-field wk-field-small wk-js2 wk-js2" id="selectLanguage" name="selectLanguage"><div data-v-b9fc59f7="" class="wk-field-header"><label data-v-b9fc59f7="" class="wk-field-label"></label> <!----> <!----> <label data-v-b9fc59f7="" class="wk-sr-only"></label></div> <div data-v-b9fc59f7="" class="wk-field-body"><div data-v-b9fc59f7="" class="wk-field-select-container"><select data-v-b9fc59f7="" tabindex="0" aria-label="Select undefined option" class="wk-field-select" name="selectLanguage" placeholder="Select a Language"><option data-v-b9fc59f7="" disabled="" value="">Select a Language</option> <option data-v-b9fc59f7="" value="zh-Hans">Chinese</option><option data-v-b9fc59f7="" value="en-US">English</option></select></div> <div data-v-b9fc59f7="" class="wk-field-inlay"><span data-v-b9fc59f7="" class="wk-field-icon wk-field-check-mark-icon"><!----></span></div> <!----></div></div></div> <div data-v-e53a75f3=""><div data-v-e53a75f3="" class="row"><div data-v-35889fff="" data-v-e53a75f3=""><label data-v-35889fff="" class="wkce-checkbox wkce-checkbox--color-primary wkce-checkbox--box-position-left is-checked"><div data-v-35889fff="" class="wkce-checkbox__checkmark-container"><input data-v-35889fff="" type="checkbox" class="wkce-checkbox__input value" id="inpText" tabindex="0" checked=""> <div data-v-35889fff="" class="wkce-checkbox__checkmark"><div data-v-35889fff="" class="wkce-checkbox__checkmark-background"></div> <div data-v-35889fff="" class="wkce-checkbox__focus-ring"></div></div></div> <div data-v-35889fff="" class="wkce-checkbox__label-text"></div></label></div> <label data-v-e53a75f3="" class="label" for="inpText">Text</label></div><div data-v-e53a75f3="" class="row"><div data-v-35889fff="" data-v-e53a75f3=""><label data-v-35889fff="" class="wkce-checkbox wkce-checkbox--color-primary wkce-checkbox--box-position-left is-checked"><div data-v-35889fff="" class="wkce-checkbox__checkmark-container"><input data-v-35889fff="" type="checkbox" class="wkce-checkbox__input value" id="inpRefs" tabindex="0" checked=""> <div data-v-35889fff="" class="wkce-checkbox__checkmark"><div data-v-35889fff="" class="wkce-checkbox__checkmark-background"></div> <div data-v-35889fff="" class="wkce-checkbox__focus-ring"></div></div></div> <div data-v-35889fff="" class="wkce-checkbox__label-text"></div></label></div> <label data-v-e53a75f3="" class="label" for="inpRefs">References</label></div><div data-v-e53a75f3="" class="row"><div data-v-35889fff="" data-v-e53a75f3=""><label data-v-35889fff="" class="wkce-checkbox wkce-checkbox--color-primary wkce-checkbox--box-position-left is-checked"><div data-v-35889fff="" class="wkce-checkbox__checkmark-container"><input data-v-35889fff="" type="checkbox" class="wkce-checkbox__input value" id="inpDisc" tabindex="0" checked=""> <div data-v-35889fff="" class="wkce-checkbox__checkmark"><div data-v-35889fff="" class="wkce-checkbox__checkmark-background"></div> <div data-v-35889fff="" class="wkce-checkbox__focus-ring"></div></div></div> <div data-v-35889fff="" class="wkce-checkbox__label-text"></div></label></div> <label data-v-e53a75f3="" class="label" for="inpDisc">Contributor Disclosures</label></div></div> <button data-v-e300e72a="" data-v-e53a75f3="" class="utd-button utd-button-size-small utd-button-color-blue utd-button-style-default utd-button-icon-right print-button" tabindex="0"><!---->Print<span data-v-e300e72a="" class="utd-button-icon wkce-icon-arrow-right" aria-hidden="true"></span></button></div> <div data-v-c9c16c06="" data-v-8430aa75="" id="slaMessageContainer"><div data-v-c9c16c06="" id="closeMessage"><a data-v-c9c16c06="" id="close" class="wkce-icon-filled-close"></a></div> <div data-v-c9c16c06="" id="slaMessage"></div></div> <!----></div> <!----> <div data-v-8430aa75="" style="display: none;"></div> <div data-v-ad72eeac="" data-v-8430aa75=""><!----> </div> <div data-v-52cbbd3c="" data-v-8430aa75="" class="calculator-tooltip"><a data-v-52cbbd3c=""></a></div> <!----> <div data-v-8430aa75="" class="topic-section-pointer wkce-icon-arrow-right topic-outline-hidden" style="top: 0px;"></div> <!---->   <!----> <!----> <!----> <!---->   <div data-v-bfe53dd8="" data-v-8430aa75="" class="topic-rating-feedback_container onlyFeedback noOutline" style="display: none;"><div data-v-bfe53dd8="" class="topic-rating-feedback_left"><!----></div> <div data-v-bfe53dd8="" class="topic-rating-feedback_right"><div data-v-e0c5c210="" data-v-bfe53dd8="" class="topic-feedback expanded expanded"><div data-v-e0c5c210=""> <a data-v-e0c5c210="" class="user-feedback-link" tabindex="0" aria-label="Provide Topic Feedback"><span data-v-e0c5c210="" class="wkce-icon-chat-box"></span> <span data-v-e0c5c210="">Topic Feedback</span></a></div></div></div></div> <div data-v-5503c416="" data-v-8430aa75="" id="topicGraphicCollection" style="display: none; padding-top: 0px; height: auto;"><div data-v-5503c416="" class="gallery-shadow" style="display: none;"></div> </div>  <div data-v-457d7431="" data-v-8430aa75="" class="utd-alert-dialog" modal-classes="translation-feedback-instruction-modal" dialog-size="medium"></div></div></div> <div style="z-index: 999999; background-color: rgb(254, 198, 41); opacity: 0; position: fixed; top: 0px; left: 0px; width: 0%; height: 3px; transition: opacity 0.6s;"></div> <footer data-v-2eaa376d="" id="utdFooter"><!----> <footer data-v-2eaa376d="" role="contentinfo" class="wk-footer"><div class="wk-footer-container"><div class="wk-footer-nav"><div class="wk-footer-nav-list"><section><h3 class="wk-footer-heading">Company</h3> <ul><li><a href="/home/about-us" track="enabled">About Us</a></li> <li><a href="/home/editorial-policy">Editorial Policy</a></li> <li><a href="/home/customer-testimonials">Testimonials</a></li> <li><a href="http://wolterskluwer.com/" class="wk-icon wk-arrow-up-right" target="_blank" rel="noopener">
                  Wolters Kluwer
                </a></li> <li><a href="http://careers.wolterskluwer.com/" target="_blank" rel="noopener" class="wk-icon wk-arrow-up-right">Careers</a></li></ul></section> <section><h3 class="wk-footer-heading">Support</h3> <ul><li><a href="/home/contact-us" track="enabled">Contact Us</a></li> <li><a href="/home/help" track="enabled">Help &amp; Training</a></li> <li><a href="/home/linking-policy">Citing Our Content</a></li></ul></section></div> <div class="wk-footer-nav-list"><h3 class="wk-footer-heading">News &amp; Events</h3> <ul><li><a href="/contents/table-of-contents/whats-new" track="enabled">What's New</a></li> <li><a href="/home/clinical-podcasts">Clinical Podcasts</a></li> <li><a href="/home/uptodate-press-releases">Press Announcements</a></li> <li><a href="/home/uptodate-news" track="enabled">In the News</a></li> <li><a href="/home/events">Events</a></li></ul></div> <div class="wk-footer-nav-list"><h3 class="wk-footer-heading">Resources</h3> <ul><li><a href="/login">UpToDate Sign-in</a></li> <li><a href="/home/earning-cme-ce-cpd-credit-uptodate">CME/CE/CPD</a></li> <li><a href="/home/how-access-uptodate">Mobile Apps</a></li> <li><a href="/home/uptodate-lfw">Webinars</a></li> <li><a href="/home/ehr-interface">EHR Integration</a></li> <li><a href="/home/uptodate-talk-podcasts">Health Industry Podcasts</a></li></ul></div> <div class="wk-footer-nav-list"><!----> <h3 class="wk-footer-heading">Follow Us</h3> <ul class="wk-social-icons-container"><li><a href="https://www.facebook.com/UpToDateEBM" class="wk-icon wk-social-icon wk-icon-facebook" target="_blank" rel="noopener noreferrer" track="enabled"></a></li> <li><a href="https://twitter.com/UpToDate" class="wk-icon wk-social-icon wk-icon-twitter" target="_blank" rel="noopener noreferrer" track="enabled"></a></li> <li><a href="https://www.linkedin.com/company/uptodate?trk=hb_tab_compy_id_21924" class="wk-icon wk-social-icon wk-icon-linkedin" target="_blank" rel="noopener" track="enabled"></a></li> <li><a href="https://www.youtube.com/uptodateebm" class="wk-icon wk-social-icon wk-icon-youtube" target="_blank" rel="noopener noreferrer" track="enabled"></a></li></ul> <div class="wk-navbar"><ul class="wk-nav utd-right"><li>Sign up today to receive the latest news and updates from UpToDate.</li> <li role="presentation" class="wk-green"><a href="https://go.wolterskluwer.com/utd_ind_cms_contact_info.html">Sign Up</a></li></ul></div></div></div> <a class="wk-logo" href="/home"><img src="https://cdn.wolterskluwer.io/wk-logos/1.0.x/wk-brand-white.svg"></a> <div class="wk-tagline">When you have to be right</div></div> <div class="wk-footer-copyright"><div class="wk-footer-copyright-container"><ul class="wk-footer-meta-info"><li><a href="/home/privacy-policy">Privacy Policy</a></li> <li><a href="/home/trademark">Trademarks</a></li> <li><a href="https://www.wolterskluwer.com/en/know/clinical-effectiveness-terms" target="_blank" rel="noopener noreferrer" track="enabled">Terms of Use</a></li> <li><a id="ot-sdk-btn" class="ot-sdk-show-settings">Manage Cookie Preferences</a></li> <div class="copyright center">© 2025 UpToDate<!----><span class="copyrightFull">, Inc. and/or its affiliates. All Rights Reserved.</span><!----><!----></div> <li class="nowrap"><span>Licensed to</span><span>: UpToDate Marketing Professional</span></li> <li><span>Support Tag</span> <span>
              : [0502 - 67.180.163.209 - D32908C91C - PR14 - UPT - NP - 20250226-08:08:14UTC] <span class="SupportTagSmall"> - SM</span> <span class="SupportTagMedium"> - MD</span> <span class="SupportTagLarge"> - LG</span> <span class="SupportTagXLarge"> - XL</span></span></li></ul></div></div></footer></footer> <!----> <div data-v-cab8f9fc="" class="trial-subscribe__container"><!----></div>  <!----> <div data-v-d3b9cb0c="" class="utd-spinner utd-spinner-with-overlay utd-spinner-fullscreen utd-spinner-locked"><div data-v-d3b9cb0c="" class="utd-spinner-container"><div data-v-d3b9cb0c="" class="utd-spinner-graphic"></div> <div data-v-d3b9cb0c="" class="utd-spinner-text"><div data-v-d3b9cb0c="" class="utd-spinner-text-heading">Loading</div> <div data-v-d3b9cb0c="">Please wait</div></div></div> <div data-v-d3b9cb0c="" class="utd-spinner-content"></div></div> <div class="utd-server-message-dialog"></div>  <!----> <!----> <!----> <div data-v-6a7d579a=""> </div> <div id="portalTarget"></div></div>
  <script type="module" src="/app/dist/index-BRqAUM3Y.min.js"></script>
  <script type="module" src="/app/dist/vendor-Bd_R3RP5.min.js"></script>
  <script type="module" src="/app/dist/utd-all-svLxXFJJ.min.js"></script>
  <script type="module" src="/app/dist/epic-BTzdswjX.min.js"></script>


<span class="tooltip-ellipsis-helper" style="display: none; height: 0px; visibility: hidden; width: auto;"></span><input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <input data-v-21d3ad54="" class="visuallyHidden utd-modal-default-focus" readonly="" tabindex="-1" aria-hidden="true" inert=""> <!----> <div id="onetrust-consent-sdk"><div class="onetrust-pc-dark-filter ot-hide ot-fade-in"></div><div id="onetrust-banner-sdk" class="otFloatingRounded otRelFont ot-bottom-left vertical-align-content" tabindex="0" role="region" aria-label="Cookie banner" style="bottom: 1rem;"><div class="ot-sdk-container" role="alertdialog" aria-describedby="onetrust-policy-text" aria-label="Your Privacy"><div class="ot-sdk-row"><div id="onetrust-group-container" class="ot-sdk-twelve ot-sdk-columns"><div id="onetrust-policy"><h2 id="onetrust-policy-title">Your Privacy</h2><p id="onetrust-policy-text">To give you the best possible experience we use cookies and similar technologies. We use data collected through these technologies for various purposes, including to enhance website functionality, remember your preferences, and show the most relevant content. You can select your preferences by clicking the link. For more information, please review our <a href="https://www.wolterskluwer.com/en/solutions/uptodate/policies-legal/privacy-policy?&amp;redirect=true" aria-label="More information about your privacy">Privacy &amp; Cookie Notice</a></p></div></div><div id="onetrust-button-group-parent" class="ot-sdk-twelve ot-sdk-columns has-reject-all-button"><div id="onetrust-button-group"><div class="onetrust-banner-options"><button id="onetrust-reject-all-handler">Reject All Cookies</button> <button id="onetrust-accept-btn-handler">Accept All Cookies</button></div><button id="onetrust-pc-btn-handler" class="cookie-setting-link">Manage Cookie Preferences</button></div><div class="banner_logo"></div></div><!-- Close Button --><div id="onetrust-close-btn-container"></div><!-- Close Button END--></div></div></div><div id="onetrust-pc-sdk" class="otPcCenter ot-hide ot-fade-in otRelFont ot-addtl-vendors" lang="en" aria-label="Preference center" role="region"><div role="alertdialog" aria-modal="true" aria-describedby="ot-pc-desc" style="height: 100%;" aria-label="Privacy Preference Center"><!-- Close Button --><div class="ot-pc-header"><!-- Logo Tag --><div class="ot-pc-logo" role="img" aria-label="Company Logo"><img alt="Company Logo" src="https://cdn.cookielaw.org/logos/2217e117-526b-4696-8a98-8c402f8f2b81/e9bcc9b6-6c71-48bf-871b-142e2cdd91dc/c8ec9024-6bd0-4585-b7bc-719cfe762386/MicrosoftTeams-image_(25).png"></div><button id="close-pc-btn-handler" class="ot-close-icon" aria-label="Close" style="background-image: url(&quot;https://cdn.cookielaw.org/logos/static/ot_close.svg&quot;);"></button></div><!-- Close Button --><div id="ot-pc-content" class="ot-pc-scrollbar"><div class="ot-optout-signal ot-hide"><div class="ot-optout-icon"><svg xmlns="http://www.w3.org/2000/svg"><path class="ot-floating-button__svg-fill" d="M14.588 0l.445.328c1.807 1.303 3.961 2.533 6.461 3.688 2.015.93 4.576 1.746 7.682 2.446 0 14.178-4.73 24.133-14.19 29.864l-.398.236C4.863 30.87 0 20.837 0 6.462c3.107-.7 5.668-1.516 7.682-2.446 2.709-1.251 5.01-2.59 6.906-4.016zm5.87 13.88a.75.75 0 00-.974.159l-5.475 6.625-3.005-2.997-.077-.067a.75.75 0 00-.983 1.13l4.172 4.16 6.525-7.895.06-.083a.75.75 0 00-.16-.973z" fill="#FFF" fill-rule="evenodd"></path></svg></div><span></span></div><h2 id="ot-pc-title">Privacy Preference Center</h2><div id="ot-pc-desc">When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device. Because we respect your right to privacy, you can choose not to allow certain types of cookies on our website. Click on the different category headings to find out more and manage your cookie preferences. However, blocking some types of cookies may impact your experience on the site and the services we are able to offer.
            <br><a href="https://www.wolterskluwer.com/en/solutions/uptodate/policies-legal/privacy-policy?&amp;redirect=true" class="privacy-notice-link" rel="noopener" target="_blank" aria-label="More information about your privacy, opens in a new tab">Privacy &amp; Cookie Notice</a></div><section class="ot-sdk-row ot-cat-grp"><h3 id="ot-category-title">Manage Consent Preferences</h3><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="C0001"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-C0001" aria-labelledby="ot-header-id-C0001"></button><!-- Accordion header --><div class="ot-acc-hdr ot-always-active-group"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-C0001">Strictly Necessary Cookies</h4><div class="ot-always-active">Always Active</div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-C0001">These cookies are necessary for the website to function. They are usually set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, this may have an effect on the proper functioning of (parts of) the site.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Vendor Details button opens Vendor List menu" data-parent-id="C0001">View Vendor Details‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="C0002"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-C0002" aria-labelledby="ot-header-id-C0002"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-C0002">Performance Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-C0002" id="ot-group-id-C0002" aria-checked="false" role="switch" class="category-switch-handler" data-optanongroupid="C0002" aria-labelledby="ot-header-id-C0002"> <label class="ot-switch" for="ot-group-id-C0002"><span class="ot-switch-nob" aria-checked="false" role="switch"></span> <span class="ot-label-txt">Performance Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-C0002">These cookies support analytic services that measure and improve the performance of our site. They  help us know which pages are the most and least popular and see how visitors move around the site.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Vendor Details button opens Vendor List menu" data-parent-id="C0002">View Vendor Details‎</button></div></div></div><!-- Groups sections starts --><!-- Group section ends --><!-- Accordion Group section starts --><!-- Accordion Group section ends --></section></div><section id="ot-pc-lst" class="ot-hide ot-hosts-ui ot-pc-scrollbar"><div id="ot-pc-hdr"><div id="ot-lst-title"><button class="ot-link-btn back-btn-handler" aria-label="Back"><svg id="ot-back-arw" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#656565" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                    l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                    c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                    s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                    L213.13,222.409z"></path></g></svg></button><h3>Performance Cookies</h3></div><div class="ot-lst-subhdr"><div class="ot-search-cntr"><p role="status" class="ot-scrn-rdr"></p><label for="vendor-search-handler" class="ot-scrn-rdr"></label> <input id="vendor-search-handler" type="text" name="vendor-search-handler"> <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110" aria-hidden="true"><title>Search Icon</title><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
            s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
            c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
            s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div class="ot-fltr-cntr"><button id="filter-btn-handler" aria-label="Filter" aria-haspopup="true"><svg role="presentation" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 402.577 402.577" xml:space="preserve"><title>Filter Icon</title><g><path fill="#fff" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
      c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
      c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
      C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></button></div><div id="ot-anchor"></div><section id="ot-fltr-modal"><div id="ot-fltr-cnt"><button id="clear-filters-handler">Clear</button><div class="ot-fltr-scrlcnt ot-pc-scrollbar"><div class="ot-fltr-opts"><div class="ot-fltr-opt"><div class="ot-chkbox"><input id="chkbox-id" type="checkbox" aria-checked="false" class="category-filter-handler"> <label for="chkbox-id"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div><div class="ot-fltr-btns"><button id="filter-apply-handler">Apply</button> <button id="filter-cancel-handler">Cancel</button></div></div></div></section></div></div><section id="ot-lst-cnt" class="ot-host-cnt ot-pc-scrollbar"><div id="ot-sel-blk"><div class="ot-sel-all"><div class="ot-sel-all-hdr"><span class="ot-consent-hdr">Consent</span> <span class="ot-li-hdr">Leg.Interest</span></div><div class="ot-sel-all-chkbox"><div class="ot-chkbox" id="ot-selall-hostcntr"><input id="select-all-hosts-groups-handler" type="checkbox" aria-checked="false"> <label for="select-all-hosts-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-vencntr"><input id="select-all-vendor-groups-handler" type="checkbox" aria-checked="false"> <label for="select-all-vendor-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-licntr"><input id="select-all-vendor-leg-handler" type="checkbox" aria-checked="false"> <label for="select-all-vendor-leg-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div></div><div class="ot-sdk-row"><div class="ot-sdk-column"><ul id="ot-host-lst"><li class="ot-host-item"><button class="ot-host-box" aria-expanded="false"></button><section class="ot-acc-hdr"><div class="ot-host-hdr"><h3 class="ot-host-name"></h3><h4 class="ot-host-desc"></h4><span class="ot-host-expand">View Cookies</span></div><!-- toggles and arrow --><div class="ot-tgl-cntr"></div></section><div class="ot-acc-txt"><div class="ot-host-opts"><!-- HOST LIST VIEW UPDATE *** --><ul class="ot-host-opt"><li class="ot-host-info"><div><div>Name</div><div>cookie name</div></div></li></ul><!-- HOST LIST VIEW UPDATE END *** --></div></div></li></ul></div></div></section></section><div class="ot-pc-footer"><div class="ot-btn-container"><button class="ot-pc-refuse-all-handler">Reject All</button> <button class="save-preference-btn-handler onetrust-close-btn-handler">Confirm My Choices</button></div><!-- Footer logo --><div class="ot-pc-footer-logo"><a href="https://www.onetrust.com/products/cookie-consent/" target="_blank" rel="noopener noreferrer" aria-label="Powered by OneTrust Opens in a new Tab"><img alt="Powered by Onetrust" src="https://cdn.cookielaw.org/logos/static/powered_by_logo.svg" title="Powered by OneTrust Opens in a new Tab"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- plus minus--><!-- Arrow SVG element --><!-- Accordion basic element --><span class="ot-scrn-rdr" aria-atomic="true" aria-live="polite"></span><!-- Vendor Service container and item template --></div><iframe class="ot-text-resize" title="onetrust-text-resize" style="position: absolute; top: -50000px; width: 100em;" aria-hidden="true"></iframe></div></div></body></html>
